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Abstract
Serotonergic (5-HT) cells o f the medullary raphe are putative central chemoreceptors, 
one o f multiple chemoreceptive sites in the brainstem that interact to produce the 
respiratory chemoreflex. This role is debated, and the importance o f 5-HT neurons as 
chemoreceptors in relatively intact systems is unclear. The main focus o f this dissertation 
is to provide further physiological evidence for the involvement and modulation o f 5-HT 
neurons in CO2 chemosensitivity. This is o f interest as a large number o f  Sudden Infant 
Death Syndrome (SIDS) cases report dysfunction in the 5-HT system, and CO2 may be 
an exogenous stressor leading to SIDS when in combination with this underlying 
vulnerability. Also, since SIDS occurs primarily during sleep, I also focus on the 
potential functional interaction between the 5-HT and hypocretinergic systems, as 
hypocretins play a role in arousal and also potentially in chemosensitivity. I confirm the 
hypothesis that the serotonergic and hypocretinergic systems modulate ventilation and 
hypercapnic ventilatory responses. Using the in situ  preparation derived from juvenile 
rats and the in vitro medullary slice preparation from mice, I verify that 5-HT neurons are 
critical in generating a response to CO2, primarily via facilitation o f the respiratory 
rhythm through 5 -HT2 receptors. I also find evidence to support the hypothesis that 
hypocretins play a significant role in the neuroventilatory response to CO2 through 
activation o f  hypocretin receptors type 1. By comparing results from rhythmic medullary 
slice preparations from wildtype (normal 5-HT function) and L m x l 0 /p (lack central 5- 
HT neurons) neonatal mice, I attempt to identify whether changes in hypoglossal nerve 
output in response to acidosis are affected by hypocretin receptors, and whether this is 
dependent on the presence o f 5-HT neurons. Frequency results from such studies are 
inconclusive; however, hypocretins do appear to mediate the burst duration response via 
serotonergic mechanisms. I also find that hypocretins facilitate baseline neural ventilatory 
output in part through 5-HT neurons. Thus, both the 5-HT and hypocretinergic systems 
are involved in modulating ventilation and hypercapnic ventilatory responses.
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1Chapter 1 General introduction
1.1. Control o f breathing
Breathing in mammals is generated in the brainstem. Neurons with respiratory- 
related activity are organized in a ventrolateral column known as the ventral respiratory 
group (VRG). Two sites have been identified as putative central rhythm generators for 
breathing, containing neurons with pacemaker-like properties that contribute to 
maintaining such a rhythm. The preBotzinger Complex (preBotC) is located at the rostral 
end o f the VRG, is both necessary and sufficient for breathing, and appears to drive 
inspiratory activity (Smith et al. 1991). More recently, the parafacial respiratory group 
(pFRG) was identified as a group o f neurons just rostral to the facial nucleus that fire 
-500  msec before inspiratory activity o f the preBotC occurs. Neurons o f  the pFRG 
appear to drive active expiratory active (Feldman and Del Negro 2006). The preBotC and 
pFRG appear to act together as a coupled oscillator to produce the respiratory rhythm 
(Feldman and Del Negro 2006; Onimaru and Homma 2003). Other nuclei in the VRG, 
including the retrotrapezoid nucleus, Botzinger complex, nucleus o f the solitary tract, 
adrenergic nuclei, and raphe nuclei, modulate the pattern o f  the respiratory rhythm 
through release o f various neuromodulators (Fig. 1.1). Neurons o f the VRG are 
anatomically linked to motor neuron pools in order to activate respiratory muscles that 
cause ventilation (Feldman et al. 2003).
Circuits generating breathing are modified by specific inputs in order to match 
ventilation to metabolic demands. Examples o f  such modulation are via feedback from 
chemoreceptors. Populations o f chemoreceptors in the periphery, carotid and aortic 
bodies, respond to fluctuations in blood gas compositions and initiate ventilatory 
responses to return blood gases to homeostatic levels (Day and W ilson 2009). Other 
populations are located within the central nervous system (central chemoreceptors) (Day 
and W ilson 2009; Feldman et al. 2003). The nature o f central chemoreception is debated 
and a topic o f  this dissertation. As will be described, serotonin-synthesizing neurons o f 
the raphe have been proposed as important central chemoreceptors.
2Breathing and chemosensitivity exhibit arousal state-dependent changes between 
sleep and wakefulness (Day and W ilson 2009; Dias et al. 2009; Gestreau et al. 2008). The 
hypocretinergic system contributes to arousal state-mediated influences on homeostasis 
(Dias et al. 2009; Gestreau et al. 2008). Hypocretin and serotonin systems are 
anatomically connected (Day and W ilson 2009; Dias et al. 2009; Gestreau et al. 2008). 
Therefore, I propose that state-dependent changes in breathing and chemosensitivity may 
be explained by hypocretin influences on 5-HT-mediated processes.
1.2. The raphe nuclei
The raphe nuclei can be divided into two major groups, rostral and caudal. The 
rostral group is located in the midbrain, includes the dorsal raphe, and projects rostrally to 
the forebrain playing roles in arousal, cognition, and mood (Dahlstrom and Fuxe 1964; 
Homung 2003; Jacobs and Azmitia 1992). The caudal group is located predominantly in 
the medulla and comprises midline nuclei such as the raphe pallidus, raphe magnus, and 
raphe obscurus in addition to the parapyramidal region located at the ventrolateral 
medullary surface. These nuclei project to other brainstem nuclei and the spinal cord 
(Dahlstrom and Fuxe 1964; Homung 2003) and are involved in pain modulation, 
temperature regulation, sexual function, cardiovascular control, and breathing (Mason 
2001; M orrison 2004). The raphe nuclei form part o f  the reticular system and are 
composed o f  mixed populations o f neurons. However, the vast majority o f  neurons 
synthesizing serotonin (5-hydroxytryptamine, 5-HT) in the central nervous system are 
located within the raphe (Hilaire and Duron 1999). Although not primarily a respiratory 
structure, the raphe has been linked to ventilation. Many raphe neurons project to 
ventilatory motor control areas such as the hypoglossal and phrenic nuclei (Holtman et al. 
1984; Jelev et al. 2001; Lalley 1986) (Fig. 1.2).
1.3. The role o f serotonin in the modulation of the eupneic respiratory rhythm
Serotonin is a major neuromodulator in the central nervous system. Raphe 5-HT- 
producing cells project to respiratory areas in the medulla and pons, including the
3reticular formation and phrenic nuclei, and these neurons alter the respiratory rhythm 
(Hilaire and Duron 1999).
Seventeen 5-HT receptor subtypes have been identified and all but the 5 -HT3 
receptor produce cellular effects via G-protein second messenger systems (Fig. 1.3; 
Kinney 2005; Richter et al. 2003). As such, 5-HT can either hyperpolarize or depolarize 
neurons, depending on the type o f  receptor to which it binds and the specific G-protein 
that is subsequently activated. Several o f the receptor subtypes have been implicated in 
modulation o f respiratory rhythm, particulary 5-HTiA, 2,4 and 1 (Hodges and Richerson 
2008).
The bulk o f  the evidence suggests that 5-HT facilitates the respiratory system. 
W ithin the medulla, in both neonatal rats and mice, 5-HT excites respiratory rhythm 
generation (Hilaire et al. 1997). Intracerebroventricular and in vitro administration o f 
agonists increase respiratory frequency (reviewed in Bianchi et al. 1995). The strength o f 
5-HT facilitation decreases with age throughout the embryonic and post-natal periods (Di 
Pasquale et al. 1992).
The dominant receptor subtype identified in the 5-HT excitatory modulation o f 
ventilation is the 5 -HT2 receptor. This receptor subtype is found extensively throughout 
respiratory-related nuclei and DOI (l-[2.5-dimethoxy-4-iodophenyl]-2-aminopropane, a 
selective 5 -HT2A/2C receptor agonist) stimulates breathing in rats in vivo and increases 
hypoglossal nerve output in vitro (Al-Zubaidy et al. 1996; Cayetanot et al. 2002). 5 -HT2 
receptor activation also depolarizes medullary respiratory neurons (both expiratory and 
post-inspiratory) in anesthetized cats (Lalley et al. 1995). 5-HT2 receptors couple with G- 
proteins that are positively coupled to phospholipase C (PLC), which mediates 
production o f  inositol triphosphate (IP3 ) and diacylglycerol (DAG) (de Chaffoy et al. 
1985). IP3 leads to calcium release from intracellular stores, and DAG activates protein 
kinase C (PKC), which inhibits potassium channels leading to membrane depolarization. 
In addition to respiratory rhythm modulation, activation o f  5 -HT2A receptors is required 
for respiratory-related rhythm generation in transverse slice preparations o f  neonatal mice 
(Pena and Ramirez 2002). This occurs via endogenous 5-HT acting on 5 -HT2A receptors,
4which modulate both transient and persistent sodium currents (required for burst 
generation) in preBotC neurons.
5 -HT4/7 receptors exert excitatory effects through positive coupling to G-proteins 
that activate adenylate cyclase thus increasing cyclic adenosine monophosphate (cAMP) 
levels, in turn activation protein kinase A (PKA) (M anzke et al. 2003). PKA activation 
directly inhibits voltage-gated potassium channels, resulting in depolarization (Bockaert 
et al. 2006). 5-HT4 receptors are abundantly expressed on preBotC neurons, cells 
involved in the generation o f the respiratory-related rhythm (M anzke et al. 2003, 2008; 
Smith et al. 1991; W enninger et al. 2004). When the 5-HT4A agonist BIMU8 is added to 
the perfusate in a perfused in situ rat brainstem preparation and injected into a live rat, 
similar results are obtained. In situ, 5-HT4A receptor activation increases phrenic nerve 
activity and in vivo it increases respiratory minute volume (Manzke et al. 2003). The role 
o f 5-HT7 receptors in breathing is still unclear, though they are also expressed in the 
preBotC (Richter et al. 2003).
5-H TiA receptors are located pre- and post-synaptically and are coupled to 
inhibitory G-proteins, causing an inhibition o f adenylate cyclase resulting in a decrease o f 
cAMP levels (Richter et al. 2003). This results in decreased neuronal excitability and 
hyperpolarization through activation o f inwardly rectifying potassium channels and 
inhibition o f N  and P/Q-type calcium channels (Ladewig et al. 2004). Receptor subtype 
1A is the m ost extensive class o f  5-HT receptors in the respiratory network (Richter et al. 
2003). An important role for this specific receptor is its autoreceptor function; ligand 
binding to somatodendritic 5-HT iA receptors inhibits 5-HT release (McCall and Clement 
1989; Veasey et al. 1995).
1.4. The hypercapnic ventilatory response
One o f the important homeostatic roles o f  the brain is to regulate arterial blood 
partial pressure o f CO2 (PCO2) an<^  pH- This is achieved via a negative feedback loop, 
with peripheral and central CO2 chemoreceptors detecting the change in PCO2 and/or pH 
and eliciting a response through an appropriate change in ventilation that maintains the
5levels in a physiological range (pH 7.35-7.45). The brain responds to increases in arterial 
blood P c c >2 by altering ventilatory parameters such as breathing frequency and tidal 
volume. However, the relative changes in these parameters are variable among species 
and across developmental stages within a single species (M ortola and Lanthier 1996; 
Putnam et al. 2005; Strohl et al. 1997). In adult rats, the ventilatory response to 7% 
inspired CO2 is an increase in minute ventilation caused by significant increases in both 
breathing frequency and tidal volume (Taylor et al. 2005). The response to high CO2 in 
rats aged 30 days post-natal (P30) is similar to the adult response. A -250%  increase in 
minute ventilation above eupnea is observed, due to an increase in both tidal volume 
(-200% ) and breathing frequency (-130% ) (Davis et al. 2006). This is relevant to my 
studies as my experimental animals were roughly 30 days o f  age.
1.5. An overview o f central chemosensitivity.
Central chemoreceptors were first identified on the ventrolateral surface o f the 
medulla (M itchell et al. 1963). Subsequent research has suggested that central 
chemosensors are located in a diffuse network including but not restricted to cells in the 
nucleus o f  the solitary tract (NTS), the locus coeruleus, the midline medullary raphe, the 
rostral ventrolateral respiratory group (rVRG), the preBotC, the fastigial nucleus, areas 
just beneath the ventral medullary surface, and the retrotrapezoid nucleus (RTN) 
(Feldman et al. 2003). M orphological cell types have been identified in at least three 
sites: glutamatergic cells in the RTN, noradrenergic cells in the locus coeruleus, and 
serotonergic cells in the medullary raphe (Richerson et al. 2005). The relative 
contributions o f  the various CCVsensitive sites to the overall breathing response induced 
by changes in CO2 are still unknown, and it is unlikely that there is a single population o f 
chemosensitive cells that display an intrinsic response to CO 2 that is similar to the 
ventilatory response o f the animal as a whole (Mitchell 2004). Local CO2 
chemosensitivity may depend on arousal state. Thus it is possible that different 
chemosensitive nuclei are responsible for altering ventilation depending on whether the 
animal is asleep or awake (see section 1.7).
61.6. The raphe and serotonergic cells as chemosensors
5-HT-containing neurons were first proposed as chemoreceptors by Richerson 
and Getting (1987). Growing evidence suggests that 5-HT neurons are likely 
chemoreceptor candidates, particularly those in the medullary raphe. 5-HT neurons are 
the single most com mon neuron type within the raphe (-25% ), and 75-90% o f these 
medullary raphe 5-HT neurons are chemosensitive despite the fact that not all o f them are 
respiratory-related (Richerson 2004; Wang et al. 2001). While no conclusive evidence 
has been found to identify the cellular mechanism responsible for sensing changes in 
P(3o2 in medullary raphe 5-HT cells, pH is most likely detected, and not CO2 directly 
(Richerson 2004). Though still not clearly understood, pH is thought to be sensed by a 
calcium-activated non-selective cation (CAN) current (Richerson 2004; W u et al. 2009). 
This current is inhibited by acidosis over a physiological range in pH (7.2 to 7.6) and is 
permeable to both potassium  and sodium (ratio 7:1, respectively). Collectively, the 
following evidence strongly suggests that 5-HT neurons are chemoreceptors.
1) Single neurons are excited by CO2 in vitro. In tissue culture, medullary raphe neurons 
increase their firing rate in response to increasing CO2, and decrease their firing rate in 
response to decreasing CO2 (W ang et al. 1998). The majority o f  these acidosis-stimulated 
neurons contain 5-HT (W ang et al. 2001). In addition, these isolated raphe neurons are 
primarily stimulated by changes in intracellular pH because when CO2 levels are changed 
while extracellular pH is kept constant, an increase in firing rate is still observed 
(Richerson 2004; W ang et al. 2002). These cell culture studies demonstrate that many 5- 
HT neurons are intrinsically chemosensitive, which is a requirement for a chemosensitive 
cell.
2) Focal acidification o f  the raphe stimulates breathing in vivo. Neurons in the raphe 
alter ventilation in response to direct and indirect changes in pH; however, this response 
is partially dependent on the arousal state o f  the animal. Focal acidification o f subregions 
o f the medullary raphe increases breathing by 15-20% during sleep in rats while CO2 
microdialysis stimulates ventilation in goats during wakefulness, but not during sleep
7(Hodges et al. 2004; Nattie and Li 2001). M icroinjection o f acetazolamide (which causes 
tissue acidosis) into the medullary raphe o f rats increases ventilation (Bernard et al.
1996).
3) Disruption o f  5-HT neurons disrupts ventilatory response to systemic CO2 in vivo.
Inhibition o f  medullary raphe neurons with muscimol (a GABAa receptor agonist) 
reduces the CO2 response in intact piglets (M essier et al. 2002). Studies using 8-OH- 
DPAT (8-Hydroxy-A,A-dipropyl-2-aminotetralin) to inhibit raphe 5-HT neurons (by 
activating inhibitory 5-H T)A receptors) also show blunting o f the CO 2 response. Focal 
inhibition o f  5-HT medullary raphe neurons by 8-OH-DPAT depresses the ventilatory 
response to inhaled CO2 in newborn piglets and adult rats (M essier et al. 2004; Taylor et 
al. 2005). In adult rats in vivo, lesions o f medullary raphe 5-HT neurons with a 5-HT 
neuron targeted neurotoxin (saporin conjugated to an antibody to the serotonin 
transporter, SERT-SAP) dampen the hypercapnic ventilatory response during sleep and 
wakefulness (Nattie et al. 2004).
4) 5-HT neurons are stimulated in response to inhaled CO2 in vivo. The only study to 
date that has published recordings made directly from 5-HT medullary raphe neurons in 
an awake, unanesthetized animal during a hypercapnic challenge was by Veasey et al. 
(1995). They found that inhalation o f  hypercapnic air increases 5-HT neuronal firing rate 
160% in cats. Furthermore, hypercapnia induces c-fos expression in the 5-HT neurons o f 
the medullary raphe (Okada et al. 2002; Teppema et al. 1997).
5) 5-HT neurons are closely associated with large arteries. In addition, 5-HT neurons 
are in close proxim ity to large medullary arteries, placing them in a functional position to 
detect blood P c o 2and make appropriate changes to maintain pH homeostasis (Bradley et 
al. 2002). This proximity to large blood vessels would allow them to faithfully sense 
arterial PCO2’ which would more closely reflect lung ventilation than would the P cc>2 ° f  
bulk cerebrospinal fluid or o f tissues near small capillaries (affected by tissue 
metabolism).
81.7. The raphe serotonergic system and the hypothalamic hypocretinergic system: 
implications for arousal state-dependent chemosensitivity
The ventilatory hypercapnic response is greater during wakefulness than sleep. 
Arousal state affects the ability for several subsets o f central chemoreceptors to respond 
to changes in CO2, including the raphe (Berthon-Jones and Sullivan 1984; Netick et al. 
1984; Phillipson et al. 1977). Also hypercapnia is a potent arousal stimulus during sleep 
(Berthon-Jones and Sullivan 1984).
1.7.1. Serotonin/raphe chemosensitivity during sleep
The raphe is not homogeneous, and raphe contributions to chemosensitivity differ 
during various arousal states. While some research shows that particular raphe subregions 
contribute equally to the ventilatory response to hypercapnia during both sleep and 
wakefulness (Nattie et al. 2004; Taylor et al. 2005), other data suggest that the 
contribution o f particular raphe areas to chemosensitivity is prevalent during sleep (Nattie 
and Li 2001). However, methods used in such studies often disrupt sleep, making it 
difficult to identify the impact o f the medullary raphe system in response to hypercapnia 
in relation to arousal state (M essier et al. 2002). Nonetheless it has been proposed that 
the raphe serotonergic system may be the dominant chemosensor during sleep (Feldman 
et al. 2003; M itchell 2004).
1.7.2. Raphe activity during sleep
Serotonergic neurons maintain wakefulness by suppressing rapid eye movement 
(REM) sleep through the release o f  5-HT (Jacobs and Fomal 1991). The raphe nucleus 
most commonly correlated with sleep is the dorsal raphe; however, the firing rate o f 
medullary serotonergic neurons also depends on arousal state (Fom al et al. 1985; Heym 
et al. 1982). Interestingly, serotonergic medullary raphe neurons (in both the raphe 
pallidus and raphe magnus nuclei) are most active during active wake states, less during 
slow wave sleep (SW S), and almost quiescent during REM sleep (Fornal et al. 1985; 
Heym et al. 1982). W hether the arousal state determines the rate o f  firing o f the 
medullary serotonergic neuron, or whether the release o f  5-HT partially contributes to the
9arousal state is uncertain. Nonetheless, the relatively constant firing o f  5-HT neurons 
during wakefulness likely provides a tonic facilitation o f ventilation, and the decrease in 
5-HT neuron activity during sleep may contribute to the decrease in ventilation observed 
during this arousal state. Sleep removes non-5-HT mechanisms contributing to CO2 
chemosensitivity, unmasking the role o f  5-HT neurons in such a response (Dias et al. 
2009; Gestreau et al. 2008; Taylor et al. 2005).
1.7.3. Hypocretinergic system
A functional interaction has been found between the serotonergic raphe neurons and 
hypocretinergic system, which could potentially influence breathing (Brown et al. 2001). 
The lateral hypothalamus and endogenous release o f  hypocretin are important 
contributors to arousal state, in addition to thermoregulation (and shivering 
thermogenesis) and feeding behavior (Sakurai et al. 1998). Neurons in the lateral 
hypothalamus synthesize hypocretin-1 (orexin A) and hypocretin-2 (orexin B) (Sakurai et 
al. 1998). These are neuropeptides derived from the com mon precursor prepro-orexin. 
Hypocretins target two G-protein coupled receptors: hypocretin receptor 1 (hcrt-rl) and 
hypocretin receptor 2 (hcrt-r2) (Fig. 1.4; Sakurai et al. 1998). These receptors have a 
different affinity for the hypocretin peptides; hcrt-rl is selective for hypocretin-1 only, 
while hcrt-r2 nonselectively binds to both hypocretin-1 and -2 (Sakurai et al. 1998). Hcrt- 
r l transmits signals through excitatory G-proteins activating PLC. Subsequent activation 
o f IP3 and PKC results in an influx o f  extracellular calcium and neuron depolarization 
(reviewed in Beuckmann and Yanagisawa 2002). Hcrt-r2 is thought to be coupled to 
either the excitatory or inhibitory G-proteins. The mechanism o f the excitatory G-protein- 
induced depolarization is similar to that o f hcrt-rl. The mechanism for hyperpolarization 
resulting from the inhibitory G-protein is unknown, but is hypothesized to be via 
potassium efflux (Beuckmann and Yanagisawa 2002).
Hypocretin neurons stimulate arousal and breathing (Ohno and Sakurai 2008; 
Young et al. 2005). Moreover, defects in the hypocretinergic system are thought to cause 
narcolepsy in both humans and animals (Chemelli et al. 1999; Peyron et al. 2000; 
Thannickal et al. 2000).
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1.7.4. Effects o f  hypocretin on ventilation
Anatomical and functional evidence suggests that endogenous hypocretins 
modulate breathing. M uch like the serotonergic system, axons o f hypocretin-containing 
neurons project to respiratory-related nuclei including the NTS, preBotC, the locus 
coeruleus, hypoglossal and phrenic nuclei (Fung et al., 2001; Hagan et al. 1999; 
Nakamura et al. 2007; Young et al. 2005). Also, areas corresponding to the preBotC and 
the phrenic m otomuclei are immunoreactive for hcrt-rl receptors (Young et al. 2005). 
Data from patients w ith various respiratory disorders hint at a correlation between 
breathing and hypocretins. Patients with Guillain-Barre syndrome, a syndrome often 
associated with respiratory paralysis, have low levels o f hypocretin in their cerebrospinal 
fluid (Ripley et al. 2001). Also, patients with sleep apnea have low blood levels o f 
hypocretin (Sakurai et al. 2005). Experimental evidence also indicates that hypocretins 
affect ventilation. Injection o f hypocretin-1 into the lateral ventricle o f a urethane- 
anesthetized mouse results in a small increase in breathing frequency (~11%) and a larger 
increase in tidal volume (-75% ) (Zhang et al. 2005).
Administration o f hypocretin-1 into the preBotC increases diaphragmatic 
electromyogram activity but does not affect breathing frequency (Young et al. 2005).
This is suggestive that hypocretin stimulates respiration primarily through increases in 
tidal volume (Young et al. 2005). The respiratory phenotype was established in a prepro- 
orexin knockout mouse (therefore lacking both hypocretin-1 and -2), often used as an 
animal model for narcolepsy. Frequency and tidal volume show sleep-wake dependency 
in both wildtype and knockout mice; however, no significant differences in minute 
ventilation are observed between the two phenotypes (Nakamura et al. 2007).
1.7.5. Link between hypocretin and 5-HT raphe neurons
M uch o f the network linking hypocretin and the raphe is described in relation to 
the dorsal raphe. Hypocretin-1 excites 5-HT dorsal raphe neurons both in slice and in 
vivo (Brown et al. 2001; Takahashi et al. 2005). In addition, hcrt-rl and 5-HT co-localize 
in the dorsal raphe, and polymerase chain reaction (PCR) studies show expression o f  both 
hypocretin receptors in 5-HT neurons in this area (Brown et al. 2002; W ang et al. 2005).
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These hypocretinergic axons synapse directly with 5-HT dendrites in the dorsal raphe 
(Nambu et al. 1999; Wang et al. 2005). Although most evidence linking hypocretin and 
5-HT neurons is based on studies o f the dorsal raphe, hypocretinergic receptors are found 
in the medullary raphe as well. Low density expression o f  both hcrt-rl and hcrt-r2 is 
found in the raphe magnus, while a moderate density o f  hcrt-rl with no expression o f 
hcrt-r2 is found in the raphe obscurus, (Marcus et al. 2001). Also, staining shows 
hypocretin axon terminals in the raphe magnus and pallidus (Nambu et al. 1999). A much 
denser innervation o f hypocretin-1 fibers to raphe pallidus is observed (Zheng et al.
2005). There are also reciprocal connections from the raphe to the lateral hypothalamus, 
though the 5-HT nerve endings terminating there mainly arise from the dorsal and 
median raphe nuclei (M uraki et al. 2004). 5-HT directly hyperpolarizes hypocretin 
neurons via 5-H T iA receptors (Muraki et al. 2004).
1.7.6. Link between hypocretin and hypercapnia
Several studies have shown correlations between the hypocretinergic system and 
hypercapnia. Hypocretin neurons themselves appear to be chemosensitive. Both 
CO2 and H+ stimulate hypocretin neurons via inhibition o f post-synaptic leak-like K+ 
channels; however, the degree o f  hypercapnia needed to produce a response is relatively 
high compared to the sensitivity o f  other neuron types (such as 5-HT neurons) (Williams 
et al. 2007). Also, Nakam ura et al. (2007) illustrate a relationship between the effect o f 
hypocretins on the response to hypercapnia and arousal state, using a knockout mouse 
lacking hypocretin-1 and -2 and a wildtype mouse, and determining sensitivity to a mild 
(5%) and severe (10%) hypercapnic challenge. These challenges increase ventilation in 
both genotypes. The wildtype shows a state-dependent sensitivity; these mice are more 
responsive when awake than during SWS or REM (Nakamura et al. 2007). However, the 
knockout shows a similar response to CO2 no matter the arousal state. No difference is 
observed in responses to hypercapnia between wildtype and knockout during sleep states. 
However, the CO2 responses during wakefulness are blunted in the knockout compared to 
the wildtype (Nakamura et al. 2007). This would suggest that hypocretins contribute to 
the increased hypercapnic sensitivity during the awake state. This complements the
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observation that hypocretin neurons fire spontaneously during wakefulness periods and 
less, or not at all, during sleep (Estabrooke et al., 2001; Lee et al. 2005). Given the 
anatomical and physiological evidence linking the hypocretinergic and serotonergic 
systems, and the involvement o f  both o f these systems in arousal, they may interact to 
promote a response to hypercapnia.
1.8. The perfused in situ juvenile rat brainstem preparation
This preparation has been widely used in recent years and is an appropriate model 
for neural control o f  ventilation studies primarily because it maintains the complexity o f 
respiratory networks (Fig. 1.5; Harris and St-John 2003; Harris et al. 2003; Paton 1996; 
St-John and Paton 2000; W ilson et al. 2001). The preparation is decerebrate; however, 
the balance o f  the central nervous system is intact, including the brainstem containing the 
entire respiratory network. As such, the in situ preparation maintains similar control o f 
the ventilatory system to that found in vivo. A comparable response to hypercapnia is 
observed both in vivo and in situ, where phrenic activity increases both in burst frequency 
and peak amplitude with increased CO2 (St-John and Paton 2000). The phrenic burst 
shapes for eupnea and gasping are similar when measured in this in situ  preparation and 
in vivo (Paton 1996; St-John and Paton 2000). In addition, the preparation receives 
adequate tissue oxygenation (W ilson et al. 2001), while more isolated brainstem 
preparations such as the en bloc preparation do not.
W hen compared to animals in vivo, this preparation has added benefit in that it is not 
influenced by anesthesia beyond the initial dissection. Also, it allows for easy 
administration o f  pharmacological agents via addition to the perfusate and equilibration 
with tissues through normal micro-circulation. One criticism is that the preparation must 
be kept hypothermic at 31°C to enhance its viability (Paton 1996). This results in a 
slower phrenic burst frequency when compared to frequencies o f  rats in vivo at euthermia 
(37°C). However, this slower breathing frequency is similar to the depression observed in 
hypothermic rats in vivo (Torbati et al. 2000). W ith the above taken into consideration,
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the perfused in situ  juvenile rat brainstem preparation is an appropriate model to 
determine the role o f  5-HT in central chemosensitivity.
1.9. Use o f a genetic model
Advancement o f molecular tools has made available animal models in which 
specific neurotransm itter systems have been genetically altered. Our model for studying 
the role o f 5-HT neurons in ventilatory control is the L m xlt/^ /p transgenic mouse. These 
mice exhibit knockout o f  the transcription factor L m xlb  selectively in central nervous 
system cells that express Pet-1, a transcription factor associated with differentiation o f 
serotonergic neurons. This results in a near-complete (>99%) and specific absence o f 
central serotonergic neurons as well as a coincident marked depletion o f central 5-HT 
(Ding et al. 2003; Zhao et al. 2006). This L m x lb ^ /p mouse is an invaluable tool as it 
enables us to focus more specifically on the role o f  serotonergic versus non-serotonergic 
neurons in central chemosensitivity. As adults, L m xlb  knockouts breathe normally at rest 
but display a blunted ventilatory response to hypercapnia (about 50% less than wildtype 
mice) and abnormal thermoregulatory responses (Hodges et al. 2008).
1.10. Ventilatory chemosensitivity and Sudden Infant Death Syndrome (SIDS)
The role o f the raphe in homeostatic reflexes, and particularly 5-HT neuron 
contributions to central chemoreception, hold significance in relation to the recent 
hypothesis that a subset o f  SIDS cases result from dysfunction in the medullary 
serotonergic system (Kinney et al. 2009; Nattie 2009). This dysfunction is proposed to 
compromise infant reflex responses to exogenous stressors (such as heat, high CO2, and 
low O2). However, the primary evidence linking SIDS with abnormalities in the 
medullary serotonergic system is anatomical, derived from radioligand binding studies.
1.10.1. SIDS triple-risk model
SIDS is defined as “the death o f an infant under one year o f  age that remains 
unexplained after a complete clinical review, autopsy, and death scene investigation” 
(Kinney et al. 2009; Nattie 2009). It is a leading cause o f infant mortality, with an overall
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incidence o f  0.6 per 1000 births (Kinney 2005). The occurrence o f  SIDS has been 
described by a triple-risk model (Figure 1.6; Filiano and Kinney 1994). This model 
proposes that SIDS is likely to occur when three factors are coincident: 1) an underlying 
vulnerability, 2) an exogenous stressor, and 3) a critical developmental time period for 
homeostatic control.
In the SIDS triple-risk model, the “critical developmental period” is presumed to 
be the period o f post-natal development, a time o f change in homeostatic control (Kinney 
et al. 2001). The greatest risk period is during the first 6 post-natal months, with a peak 
risk at 2-4 months (Kinney 2005).
The underlying vulnerability is a physiological condition that impairs the infant’s 
response to life-threatening situations imposed by the exogenous stressors. The 
exogenous stressors are commonly occurring but potentially life threatening 
circumstances such as an increase in Pcc>2- These circumstances are normally overcome 
by critical homeostatic reflexes such as the hypercapnic ventilatory response. The model 
proposes that, in a vulnerable infant, reflex responses are compromised such that 
exogenous stressors can not be overcome, resulting in SIDS (Filiano and Kinney 1994). 
Much current research is devoted to identifying factors contributing to “underlying 
vulnerability” to SIDS. One factor is hypothesized to be malfunction in the brainstem 
serotonergic system.
1.10.2. The serotonin malfunction hypothesis fo r  SIDS
The serotonin malfunction hypothesis was proposed based on increasing 
anatomical evidence o f abnormalities in the medullary 5-HT system in SIDS cases. The 
medullary 5-HT system is abnormal in at least 50% o f SIDS cases (Kinney 2005). In two 
separate datasets o f  SIDS cases, Kinney et al. (2001, 2003) measured 5-HT binding 
density using quantitative autoradiography with the nonselective radioligand 3H-LSD, 
which binds to 5-H T iA-d and 5-HT2 receptors. They found that in both datasets, 5-HT 
receptor binding was significantly lower in the arcuate nucleus and the raphe obscurus in 
SIDS cases when compared to age-matched controls. This is particularly interesting due 
to evidence o f  a relationship between the arcuate nucleus and the raphe nuclei to
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chemosensitivity (Paterson et al. 2006a; Richerson 2004). Although the Kinney et al. 
(2001, 2003) studies are important for their demonstration o f altered receptor binding 
density, they do not specify which receptor subtypes are involved. In a more recent study, 
Paterson et al. (2006b) looked at the 5-HT neuron count and density, 5-H T ia receptor 
binding density, and 5-HTT (the 5-HT reuptake transporter that controls the amount o f 5- 
HT in the synaptic cleft) binding density in SIDS cases compared to age-matched 
controls. The 5-HT neuron count and density are significantly higher in SIDS cases in 
regions o f  the midline raphe, lateral extraraphe, and ventrolateral medullary surface; 
however, many o f these neurons are immature (non-functional). 5-H T ia receptor binding 
is significantly lower in SIDS cases in all nuclei tested, excluding the inferior olive. No 
differences are seen in 5-HTT binding density. The ratio o f  5-HTT to the 5-HT neuron 
count is lower in the raphe obscurus, indicating a relative reduction o f 5-HTT expression 
per 5-HT neuron. The above abnormalities, however, do not indicate if  there is an excess 
or a deficit o f available 5-HT in SIDS cases. W hat remains to be determined is the level 
o f available 5-HT in normal versus SIDS brainstems. In general, dysfunction in normal 
homeostatic regulation via 5-HT is presumed to contribute to SIDS vulnerability.
1.11. Relevance o f dissertation research to an understanding o f SIDS
It is not the intent o f  this dissertation to use the perfused in situ juvenile rat 
preparation as a model for SIDS. I aim to identify the functional consequences o f 
pharmacologically induced serotonergic dysfunction in this animal model system. These 
data will identify if  experimentally induced 5-HT system dysfunction can compromise 
critical homeostatic reflexes which, if  occurring in an infant, would enhance vulnerability 
to SIDS. My studies are relevant in that they provide further physiological evidence to 
support the hypothesis that a subset o f SIDS cases is due to abnormalities in the 
medullary serotonergic system, which may prevent vulnerable infants from responding 
appropriately to exogenous stressors such as high CO2.
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1.12. Aims
The experimental focus o f  this dissertation is to provide further physiological 
evidence for the link between serotonin malfunction and faults in CO2 chemosensitivity. 
CO2 may be a key exogenous stressor in SIDS cases. Since SIDS occurs primarily during 
sleep, I also focus on the potential functional interaction between the serotonergic and 
hypocretinergic systems, as hypocretins are known to play a role in arousal and 
potentially in chemosensitivity. I achieve much o f this focus by using an unanesthetized 
in situ  perfused juvenile rat brainstem preparation. This preparation is innovative in that 
previous raphe chemosensitivity studies have been performed using either anesthetized 
animals or reduced preparations such as in vitro brainstem preparations or cell cultures, 
which do not maintain the connectivity o f  respiratory networks. The following 
experiments were designed to address specific aims that support the overarching 
hypothesis: the serotonergic and hypocretinergic systems are involved in modulating 
ventilation and hypercapnic ventilatory responses.
Specific Aim I. To identify that 5-HT neurons and specific 5-HT receptor subtypes 
are involved in the hypercapnic neuroventilatory response in situ.
I test the hypothesis that the 5-HT system is involved in modulating the neuroventilatory 
rhythm in response to hypercapnia. Using the unanesthetized in situ  perfused juvenile rat 
brainstem preparation (from here on referred to as the in situ  preparation), I first define 
the changes in neuroventilation caused by altering levels o f CO2 in the perfusate. This is 
achieved by recording phrenic nerve burst parameters (frequency and amplitude) and 
using them as neural correlates for ventilatory parameters (breathing frequency and tidal 
volume). I then identify the importance o f  5-HT neurons, and 5-HTi and 5 -HT2 receptors 
in neuroventilatory responses to hypercapnia, by pharmacological alteration o f  the 5-HT 
system during a hypercapnic challenge. I expect that disruption o f the 5-HT system will 
alter neuroventilation and dampen the neuroventilatory hypercapnic response. Thus these 
studies will illustrate the contribution o f the serotonergic system in neuroventilation and 
chemosensitivity. (Chapter 2)
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Specific Aim II. To identify the role o f the hypocretinergic system in 
neuroventilation and the hypercapnic neuroventilatory response. I test the hypothesis 
that hypocretins contribute to neuroventilation and promote the hypercapnic 
neuroventilatory response. Using the in situ  preparation, I identify the effects o f 
hypocretin-1 adm inistration and o f hcrt-rl antagonism on phrenic neuro ventilation, and 
changes in neuroventilation with hypercapnia (chemosensitivity). I also identify the 
effects o f hypocretin-1 on the hypoglossal nerve output in a neonatal rat rhythmic 
medullary slice preparation. I predict that addition o f hypocretin-1 will stimulate 
neuroventilation and enhance chemosensitivity. Conversely, antagonism o f hcrt-rl is 
expected to dampen neuroventilation and blunt chemosensitivity. Thus these studies will 
illustrate the contribution o f the hypocretinergic system to neuroventilation and 
chemosensitivity. (Chapter 3)
Specific Aim III. To identify the role o f serotonin neurons and o f hypocretinergic 
modulation in the neuroventilatory response to acidosis. The objectives in this 
Specific Aim are two fold. The first sub-aim is to establish that serotonergic neurons are 
important in central sensitivity to pH. I test the hypothesis that serotonin neurons 
contribute to the neuroventilatory response to acidosis in an in vitro rhythmic medullary 
slice preparation. I determine the response o f hypoglossal nerve output to changes in pH 
in a medullary slice preparation derived from a wildtype and L m x l 0 /p mouse (which 
lacks central serotonergic neurons). I expect that responses in slices lacking central 
serotonergic neurons will be blunted compared to responses in wildtype slices.
The second sub-aim is to establish that hypocretinergic modulation o f 
neuroventilation and chemosensitivity is determined by an impact o f  hypocretin on 5-HT 
neurons. I test the hypothesis that hypocretins contribute to neuroventilation and promote 
the neuroventilatory response to acidosis through serotonergic neurons. In rhythmic 
medullary slices derived from wildtype and Lm xlbf^/p mice, I identify whether changes in 
hypoglossal nerve activity generated by hypocretin-1 and hypocretin receptor antagonists 
depend on the presence o f  5-HT neurons. I also identify the effects o f hypocretin receptor 
antagonism on hypoglossal nerve responses to acidosis and whether or not this is
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dependent on the presence o f 5-HT neurons. I expect that responses in slices lacking 5- 
HT neurons will be blunted compared to wildtype slices. Thus these studies will illustrate 
the 5-HT neuron-dependence o f hypocretinergic impacts on neuroventilation and 
chemosensitivity (Chapter 4).
Rostral
Figure 1.1 Dorsal view of rat brainstem and cervical spinal cord indicating the regions 
important in the generation of breathing. Abbreviations include: A5, pontine A5 group; 
RTN, retrotrapezoid nucleus; BotC, Botzinger complex; preBotC, preBotzinger complex; 
rVRG, rostral ventral respiratory group; NTS, nucleus tractus solitarius; cVRG, caudal 
ventral respiratory group. Modified from Rekling and Feldman 1998.
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Figure 1.2 Schematic of the anatomical connections between the medullary raphe, and 
respiratory-related nuclei and motonuclei. Abbreviation XII indicates hypoglossal motonuclei. 
From Richerson 2004.
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Figure 1.3 Schematic o f cellular pathways activated by 5-HT receptor subtypes 
associated with breathing. Shown are some o f the known (arrow= activation, blunt line = 
inhibition) and postulated (question marks) pathways and effectors through which 5-HT 
affects membrane excitability. Abbreviations include: AA, arachidonic acid; DAG, 
diacylglycerol; GIRK, G-protein-gated inwardly rectifying potassium channel; IP3, 
inositol trisphosphate; KV, voltage-gated potassium channel; PIP2 phosphatidylinositol 
bisphosphate; PK, protein kinase; PL, phospholipase; SK, small conductance calcium- 
activated potassium channel; TASK, TW IK-related acid-sensitive potassium channel. 
M odified from Hodges and Richerson 2008.
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Figure 1.4 Schematic of hypocretinergic signaling. Neuropeptides hypocretin-1 and -2 are 
derived from a common precursor gene. Hypocretin-1 can bind with both hypocretin receptor 
types (hcrt-rl and hcrt-r2) while hypocretin-2 has high affinity only for hcrt-r2. Modified from 
Beuckmann and Yanagisawa 2002.
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Figure 1.5 Schematic of the perfused in situ juvenile rat brainstem preparation. Artificial 
cerebrospinal fluid (aCSF) is equilibrated with a gas mixture (95% 0 2/ 5% C 0 2 during control 
conditions) and pumped by a roller pump through a bubble trap and filter before entering the 
descending aorta via a double-lumen catheter. Phrenic nerve activity is recorded via a glass 
suction electrode and monitored by a computer data acquisition system. Phrenic nerve burst 
parameters are characterized as burst duration, inter-burst interval (period between the bursts), 
burst amplitude, and burst frequency. Included is sample of a raw trace (top) and integrated trace 
(bottom) of phrenic nerve output.
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Figure 1.6 The triple-risk model proposes that an infant may die of SIDS if 3 factors occur 
simultaneously: 1) an underlying vulnerability, 2) an exogenous stressor, and 3) a critical 
developmental time period for homeostatic control. Adapted from Kinney et al. 2001.
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Chapter 2 Serotonergic mechanisms are critical for central 
neuroventilatory chemosensitivity in s /W
Abstract
Studies in vitro suggest that serotonin-synthesizing neurons (5-HT neurons) may 
be important for CO2 chemosensitivity. The roles o f these neurons in modulating 
breathing in vivo, however, are less clear. We used a perfused in situ  juvenile rat 
brainstem preparation that exhibits patterns o f  phrenic nerve discharge akin to breathing 
in vivo. Exposure o f  this preparation to hypercapnia increased phrenic burst frequency 
and/or amplitude, neural correlates o f  hypercapnic ventilatory responses in breathing 
frequency and tidal volume in vivo. This study was designed to assess the importance o f 
5-HT neurons and 5-HT receptor activation in modulating frequency and amplitude 
components o f  the hypercapnic neuroventilatory response. Neuroventilatory responses to 
hypercapnia were assessed without and with application o f methysergide (5-10 pM, a 
mixed 5-HT 1 /2  receptor antagonist), 8-OH-DPAT (1.5 pM, an agonist o f 5-HTia), and 
ketanserin (5 pM, a 5-HT2 antagonist). All pharmacological manipulations abolished 
hypercapnic responses. Our data illustrate that 5-HT neurons and 5-HT receptor 
activation are critical for CO2 responses in situ, and support a hypothesis that such 
neurons play an important role in central ventilatory chemosensitivity in vivo.
2.1. Introduction
Brainstem serotonin-synthesizing neurons (5-HT neurons) project widely throughout the 
central nervous system, and comprise a complex and broad neuromodulatory system 
(Jacobs and Azm itia 1992). 5-HT neurons have been implicated in the modulation o f
1 Corcoran, A.E., Richerson, G.B., and Harris, M.B. 2009. Serotonergic mechanisms are critical for central 
neuroventilatory chemosensitiviy in situ. Prepared for submission to the American Journal of Physiology: 
Regulatory, Integrative and Comparative Physiology.
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brainstem respiratory neurons, influencing breathing in a num ber o f ways, ranging from 
facilitation and/or stabilization o f the respiratory-related rhythm ogenesis in vitro (Pena 
and Ramirez 2002; Ptak et al. 2009; Richter et al. 2003) to the generation and/or 
stabilization o f gasping (Toppin et al. 2007; Tryba et al. 2006). Substance P (SP) and 
thyrotropin-releasing hormone (TRH) both co-localize in many medullary 5-HT neurons, 
suggesting that these neurons may act via a range o f post-synaptic mechanisms that could 
involve neurotransmission via a combination o f 5-HT, SP, and/or TRH (Holtman et al. 
1984).
Much evidence shows that 5-HT neurons are critically involved in the brain’s 
ability to effectively detect changes in P c c ^ P H  and elicit ventilatory responses that 
return arterial blood gases to a homeostatic level (see Corcoran et al. 2009a; Richerson 
2004 for review). The medullary raphe, composed in large part o f 5-HT neurons, has 
been identified as one o f the primary sites for central chemosensitivity (Bernard et al. 
1996; Dias et al. 2007; Hodges et al. 2004; M essier et al. 2002; Nattie and Li 2001; Nattie 
et al. 2004; Penatti et al. 2006; Taylor et al. 2005; Veasey et al. 1995). 5-HT mechanisms 
are linked to central chemosensitivity, as treatments with selective 5-HT reuptake 
inhibitors augment ventilatory responses to hypercapnia in intact animals, whereas 
pharmacologic inhibition or neurotoxic lesions within specific subsets o f 5-HT neurons 
decrease such responses (Nattie et al. 2004; Taylor et al. 2004, 2005). More recently, 
genetically modified mice illustrate that 5-HT neurons contribute to hypercapnic 
ventilatory responses. Adult male Pet-1'7' mice, which lack 70% of central 5-HT neurons, 
display a blunted CO2 response (Hodges et al. 2005). Also, mice exhibiting a more 
extreme phenotype in which the transcription factor L m xlb  has been selectively knocked 
out in Pet-1-expressing cells (L m x lb ^ /p; resulting in >99% loss o f central 5-HT neurons) 
have a 50% reduction in the hypercapnic ventilatory response compared to wildtype 
(Hodges et al. 2008). A partial deficit in CO2 chemosensitivity in animals lacking some 
or all 5-HT neurons implicates 5-HT neuron-mediated mechanisms in such 
chemosensitivity in vivo. It is not clear if  the residual chemosensitivity represents 5-HT 
neuron-independent chemosensitive mechanisms that normally contribute to ventilatory
38
responses, or if  it results from compensatory mechanisms emergent in genetically 
modified experimental systems.
Hypercapnic acidosis increases the firing rate o f 5-HT neurons in rat primary cell 
culture and acute brainstem slices (Richerson 1995; Wang et al. 2001). A subset o f  5-HT 
neurons function as respiratory chemoreceptors and alter ventilation to maintain blood 
gas/pH homeostasis (reviewed by Richerson 2004). This proposed role o f  5-HT neurons, 
and the neurotransm itter and receptor mechanisms involved, however, remain 
controversial (Richerson et al. 2005; Guyenet et al. 2005).
M uch o f  the research supporting a critical role o f  5-HT neurons in ventilatory 
chemosensitivity in rodents has been performed in primary cell culture and acute 
brainstem slices (W ang et al. 1998, 2001, 2002). Criticism o f these studies suggests that 
5-HT neuron chemosensitivity in vitro may not reflect chemosensitive mechanisms 
functioning in vivo. The latter opinion, however, is primarily based on studies conducted 
in anesthetized in vivo preparations, without consideration o f the potential confounding 
influences o f  anesthesia, the age o f animals tested, or the specific location o f  5-HT 
neurons under investigation (see Corcoran et al. 2009a for review). The experimental 
system used in our current study, the unanesthetized, decerebrate arterially perfused in 
situ juvenile rat brainstem preparation (Paton 1996), retains the complexity o f intact 
respiratory networks in vivo, while avoiding potentially confounding influences o f 
anesthesia or em ergent properties o f genetically modified model organisms. Numerous 
studies have validated that this perfused in situ  brainstem preparation exhibits 
neuroventilatory activity patterns representative o f  automatic ventilation comparable to 
eupnea in vivo, and that this preparation retains sensitivity to hypercapnic acidosis (Day 
and W ilson 2005; St-John and Paton 2000; Toppin et al. 2007). In the present 
investigation, we used the perfused in situ  brainstem preparation to assess the importance 
o f 5-HT neuromodulation in altering respiratory drive in response to hypercapnia. The 
aim o f this study was to evaluate the hypothesis that 5-HT neurons and 5-HT 
neuromodulation are critical in the hypercapnic neuroventilatory responses in our 
relatively intact preparation.
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2.2. Methods
2.2.1. Experimental preparations
Animal husbandry and experimental procedures conformed to guidelines set by 
the National Institutes o f  Health Office o f Laboratory Animal Welfare and the United 
States Department o f  Agriculture Animal Welfare Act, and were approved by an 
Institutional Animal Care and Use Committee o f  the University o f  A laska Fairbanks. 
Juvenile male albino rats (24-30 days old; 70-140 g; Sprague-Dawley strain; Charles 
River and Simonson Laboratories) were used to derive decerebrate arterially perfused in 
situ  brainstem preparations, as previously described (St-John and Paton 2000; Toppin et 
al. 2007). This general method varied slightly depending on the experimental series; 
differences are indicated where applicable. Briefly, animals were pretreated with 
intraperitoneal heparin sodium injection (0.7 -  1.5 mis, 1000 USP; Baxter, Deerfield, IL) 
to prevent blood clotting during subsequent surgery. Procedures were preceded by deep 
anesthesia using halothane in experimental series I and isofluorane in series II and III. 
Anesthesia was assessed by an absence o f withdrawal response to firm toe pinch and 
cessation o f spontaneous breathing movements. Anesthesia was discontinued as animals 
were decerebrated rostral to the superior colliculi, and subsequent procedures were 
conducted in the absence o f  anesthesia. Preparations were bisected below the diaphragm 
and immersed in ice-chilled saline. Preparations were then placed, supine (series I and II) 
or prone (series III), in a recording chamber. The descending aorta was cannulated with a 
double-lumen catheter and preparations perfused with 31°C solution. The perfusate 
contained the following in distilled water: M gS04  (1.0 mM); KH2PO4 (0.25 mM); KC1 
(4.0 mM); N aH C 0 3 (25 mM); NaCl (115 mM); CaCl2 (2.0 mM); dextrose (10 mM) and 
Ficoll 70 (0.1785 mM). Under baseline conditions, the perfusate was equilibrated with 
95% C>2-5% CO2 (perfusate pH ~7.4). Perfusion pressure was maintained at either 
approximately 80 mmHg (series I), or 40-60 mmHg (series II and III) by adjustments in 
flow rate achieved through regulating the speed o f  a peristaltic perfusion pump. The 
initial 50 ml o f perfusate circulated through each preparation was discarded to eliminate 
residual blood, and the remaining volume (approximately 300 ml) was collected and
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recirculated. The neuro-muscular blocker gallamine triethidodide (60 mg/L) was added to 
the perfusate to eliminate spontaneous respiratory movements. One phrenic nerve was 
isolated from the diaphragm and drawn into a glass suction electrode to record efferent 
nerve activity (phrenic neurogram). The signal was amplified (x 10,000; DAM50, WPI) 
and filtered (band-pass 10 Hz -  1 kHz). In series I, data were digitized at 2 kHz and 
archived with a computer data acquisition system (DataPac, Advance Instrument). 
Digitized data were full-wave rectified and averaged over 50 msec intervals. In series II 
and III, phrenic neurogram data were digitized at 2 kHz (ADInstruments, Powerlab), 
directly and again on a second channel after being passed through a moving averager 
(CWE; 50 msec time constant).
2.2.2. Treatments: pharmacological agents and hypercapnia
We altered 5-HT neuron activity or 5-HT neuromodulation by administering 
agonists and antagonists o f the 5-HTi and/or 5 -HT2 class o f receptors in three 
experimental series. As a mixed 5-HTi and 5-HT2 receptor antagonist, methysergide 
maleate was used in concentrations (5-10 pM; series I). The 5-H T iA receptor agonist (R)- 
(+)-8-hydroxy-2(di-«-propylamino) tetralin (8-OH-DPAT; 1.5 pM ) was administered in 
series II. Populations o f 5-HT ia receptors are located on serotonin-releasing neurons and 
act as autoreceptors. Activation o f  5-H T iA autoreceptors through 8-OH-DPAT (or 
endogenous extracellular serotonin) results in hyperpolarization, decreased 5-HT neuron 
firing, and reduced neurotransmitter release (McCall and Clement et al. 1989; Sharp et al. 
1989). 8-OH-DPAT is commonly used in respiratory studies to alter 5-HT neuron 
transmitter release (M essier et al. 2004, Taylor et al. 2005). Finally, in the third 
experimental series, we administered the high affinity 5 -HT2 class receptor antagonist 
ketanserin tartrate (ketanserin; 5 pM). All drugs were obtained from Sigma Aldrich. Drug 
doses were chosen that saturate targeted receptor pools (higher than published Ki values 
in other systems; Herndon et al. 1992; Marazziti et al. 1997; Newman-Tancredi et al. 
1998) and that were lower than those shown to obscure eupneic burst pattern in our 
preparation (Toppin et al. 2007).
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The level o f  CO 2 bubbled in the perfusate to administer hypercapnia varied 
between the experimental series and was chosen to elicit biologically relevant changes in 
neuroventilation. In all series baseline CO2 was 5% (normocapnia). In series I, 7% CO2 
was chosen for the hypercapnic challenge, while 9% was used in series II and III. A 
subset o f pilot experiments exhibited abnormally high baseline breathing frequencies and 
paradoxical ventilatory responses to hypercapnia. As consistent ventilatory responses 
were obtained in the majority o f  preparations exhibiting baseline frequencies below 50 
bursts/minute, preparations exhibiting baseline frequencies greater than 50 bursts/minute 
were excluded from present analysis. The range o f  frequencies exhibited by preparations 
included in our studies match those commonly reported by other researchers using this 
preparation.
2.2.3. Experimental protocols
Series I: methysergide
Phrenic nerve activity was monitored for roughly 40 minutes under control 
conditions, and for 10 minutes subsequent to a switch to a hypercapnic perfusate. Phrenic 
burst parameters during the last 5 minutes o f the CO2 application were analyzed and 
compared to the 5 minutes prior to the hypercapnic challenge, to determine hypercapnic 
sensitivity. This hypercapnic exposure protocol was conducted, either in the absence o f 
pharmocological m anipulation (sham treatment; n = 4) or when methysergide was present 
in both control and hypercapnic perfusates at either 5 (n -  4) or 10 (n = 4) pM.
Series II: 8-OH-DPAT
During this series, phrenic burst frequency tended to increase over time (also 
reported by Day and W ilson (2005), although not observed in Series I) but stabilized after 
approximately 60 minutes. Neuroventilatory activity was monitored for 6 0 - 7 5  minutes 
to assure a stable baseline. In pilot and control experiments, repeated C 0 2 exposures 
produced consistent and repeatable increases in phrenic burst frequency with hypercapnia 
in a given preparation (data not shown). As such, a repeated measures design was 
employed, with all 6 animals undergoing a hypercapnic challenge both before and
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following 8-OH-DPAT application. Preliminary experiments revealed that 5 minutes was 
sufficient to reach the maximal neuro ventilatory response to this level o f  hypercapnia.
After baseline measurements, the preparation was exposed to hypercapnia via the 
perfusate and then returned to normocapnia for an additional 5 minutes. A final 
concentration o f 1.5 pM  8-OH-DPAT was applied during exposure to normocapnia. After 
5 minutes, the hypercapnic challenge was repeated under the continued influence o f 8- 
OH-DPAT. Phrenic activity during the last minute o f  normocapnia, hypercapnia, 
normocapnia, normocapnia with 8-OH-DPAT, and hypercapnia with 8-OH-DPAT were 
analyzed.
Series III: ketanserin
As with the second series, preparations were subjected to an equilibration period 
o f ~ 60 minutes to achieve stable baseline phrenic burst activities. This experimental 
series also utilized a repeated measures design (n = 8). After a stable baseline was 
reached, preparations were exposed to 5 minutes o f hypercapnia followed by 5 minutes o f 
normocapnia. Ketanserin was added to the perfusate (5 pM) and, following 5 minutes o f 
normocapnic ketanserin exposure, the hypercapnic challenge was repeated. Phrenic 
activities o f the final minute o f normocapnia, hypercapnia, normocapnia, normocapnia 
with ketanserin, and hypercapnia with ketanserin were analyzed.
2.2.4. Data and statistical analyses
We monitored phrenic nerve activity as an index o f  central respiratory output. 
Samples were taken for analysis for each treatment, in each series, as indicated above.
The moving averages o f  phrenic nerve discharge were quantified as: duration o f burst 
(neural inspiration, Ti), inter-burst interval (the period between the bursts, the index o f 
neural expiration, TE), individual burst frequency (fR: 60/( Ti + TE), and burst peak 
amplitude (established as a neural index o f tidal volume; nV r; Eldridge 1971). Neural 
minute ventilation was calculated as the product o f  fR and nVr. The maximum response 
to CO2 was evaluated by calculating the hypercapnic value as a proportion o f 
normocapnic value. This was repeated with values obtained during drug exposure. Data
43
from both drug doses in the methysergide series (series I) were pooled as the responses 
were not significantly different from one another (Student’s t-test). To determine if 
hypercapnia had an effect on neuroventilation, and whether or not a given 
pharmacological manipulation affected the magnitude o f this response, two-way 
repeated-measures ANOVA were performed on absolute values for all variables except 
nVj. Phrenic amplitude was recorded in arbitrary units. To establish the statistical 
significance o f the effect o f CO2 on this parameter, a paired t-test was used on the 
normalized values. To evaluate the effect o f pharmacological application on baseline 
firing, paired t-tests were used for all parameters. Data are expressed as mean ± SE. The 
criterion level for determination o f statistical significance was set at P < 0.05.
2.3. Results
2.3.1. Eupnea
Baseline normocapnic values for parameters o f  phrenic nerve activity did not 
differ between experimental series (see Tables 2.1, 2.2 and 2.3 for individual series and 
group values). Under initial normocapnic conditions, phrenic bursts occurred at a mean 
rate o f 29.9 ± 2.2 bursts/minute. The burst duration (TO was 0.46 ± 0.03 seconds and the 
period between bursts (T e) was 1.78 ± 0.15 seconds. Bursts exhibited the typical 
incrementing pattern normally associated with eupneic integrated phrenic nerve discharge 
in this in situ  preparation (Paton 1996; St-John and Paton 2000).
2.3.2. Series I: methysergide
Hypercapnic response
Four preparations were subjected to a hypercapnic challenge by increasing the 
level o f CO2 equilibrating the perfusate (Fig. 2.1). Neuroventilatory changes were limited 
to a significant augm entation in phrenic burst frequency (increase o f 30 ± 3% above 
control) mediated entirely by a decrease in the duration o f neural expiration (to 74 ± 1 % 
o f control). The burst length remained unaffected. There was a significant decrease in 
neural tidal volume as determined by peak phrenic amplitude (to 73 ± 8% of control). As
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a result, the neural equivalent o f minute ventilation (obtained by multiplying the 
integrated phrenic amplitude with burst frequency) was not altered in response to 
hypercapnia (93 ± 9% o f control) (Fig. 2.2).
Drug effect on eupnea and the hypercapnic response
We administered methysergide to eight preparations, achieving final perfusate 
concentrations o f 5 and 10 pM (n = 4 for each dose). Compared to control preparations, 
methysergide-treated preparations had greater burst frequency at baseline CO2 (66 ± 18% 
greater than control) due to a lower Te (to 58 ± 5 % o f control) (Fig. 2.3). Importantly, 
frequencies greater than these values were routinely observed in drug-free hypercapnic 
conditions. M ethysergide effects did not induce maximal burst frequencies. Peak 
amplitude was also slightly lower in methysergide-treated preparations. Responses to 
hypercapnia were statistically identical between the two methysergide doses; thus data 
for methysergide treatments were pooled. Hypercapnic responses were significantly 
different between methysergide-treated and control preparations (Fig. 2.1). W hen 5-HT 1 
and 5 -HT2 receptors were inhibited, none o f the phrenic burst param eters changed with 
an elevation o f  CO 2.
2.3.3. Series II: 8-OH-DPAT
Hypercapnic response
In a second set o f experiments, exposure to hypercapnia resulted in a significant 
neuroventilatory response (n = 6). Neural minute ventilation was augmented 14 ± 5% 
above the control value (Fig. 2.2). Phrenic burst frequency increased by 12 ± 6%; 
however, no significant changes were observed in the period between bursts nor the burst 
length (Fig. 2.4). No consistent change in integrated peak phrenic amplitude was 
observed in conjunction with the increase in frequency with hypercapnia.
Drug effect on the hypercapnic response
Eupneic bursts continued following administration o f 1.5 pM  o f 8-OH-DPAT. 
While the frequency o f  phrenic bursts was not altered, Ti was significant increased (to 15 
± 3 % above control) (Fig. 2.3). Peak amplitude was also significantly increased (to 14 ±
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4% above control). Frequency response to hypercapnia in untreated preparations was 
absent in the presence o f  8-OH-DPAT (Fig. 2.4). In addition, treatment with 8-OH-DPAT 
abolished the hypercapnic response o f  neural minute ventilation.
2.3.4. Series III: ketanserin
Hypercapnic response
Increasing the CO2 equilibrating the perfusate resulted in a significant increase in 
phrenic burst frequency in this series (to 10 ± 4% above control) (Fig. 2.5). The elevated 
frequency was the result o f  a decrease in the period between bursts (to 89 ± 4% of 
control). The frequency response was accompanied by a significant increase in peak 
phrenic amplitude (to 8 ± 2% above control), resulting in a considerable increase in 
neural minute ventilation (to 20 ± 4% above control) (Fig. 2.2).
Drug effect on eupnea and  the hypercapnic response
Ketanserin (5 pM) did not alter eupneic burst pattern in any o f  the eight 
preparations (Fig. 2.3). However, this dose was sufficient to abolish the neuroventilatory 
response previously evoked by exposure to hypercapnia (Fig. 2.5). W hen 5 -HT2 receptors 
were blocked, hypercapnia did not result in any significant changes in phrenic burst 
parameters.
2.4. Discussion
2.4.1. Chemosensitivity o f  the in situ preparation
Our primary objective was to determine if  5-HT neurons and 5-HT receptor 
activation are critical for central chemosensitivity. Thus, our first aim was to confirm that 
our experimental system, the arterially perfused in situ  preparation, exhibited biologically 
relevant responses to hypercapnia. Such responses have been identified in previous 
studies (Day and W ilson 2005, 2007; St-John and Paton 2000). In vivo, animals respond 
to increases in arterial blood P cc >2 altering ventilatory param eters such as breathing 
frequency and tidal volume. However, the relative changes in these parameters are
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variable among species and across developmental stages within a single species. In adult 
rats, the ventilatory response to inhaling 7% CO2 is an increase in minute ventilation 
caused by significant increases in both breathing frequency and tidal volume (Taylor et 
al. 2005). The response to high CO2 in rats aged 30 days post-natal (P30) is similar to the 
adult response. A  -250%  increase in minute ventilation is detected when compared to 
eucapnic values, due to both an increase in tidal volume (-200% ) and breathing 
frequency (-130% ) (Davis et al. 2006). Both central and peripheral chemoreceptors 
contribute to these responses, with approximately 60% o f the magnitude o f the 
hypercapnic ventilatory response due to central chemoreceptor activation (Smith et al.
2006). The perfused in situ  brainstem preparation has deactivated peripheral 
chemoreceptors (Day and W ilson 2007) and would be expected to exhibit dampened 
chemosensitivity more commonly associated with peripherally denervated rodents 
(Gautier et al. 1993; Nattie et al. 1991). Additionally, the in situ  preparation is 
decerebrate and vagotomized, both o f which blunt the ventilatory response to 
hypercapnia in vivo (M artin-Body and Sinclair 1987; Nattie et al. 1991). Also, since the 
preparation is maintained at a mildly hypothermic temperature (3 1°C), neuroventilatory 
responses to CO2 are expected to be diminished as is observed with hypothermic 
hypercapnia in vivo (M askrey 1990). In general, with the impact o f  all these factors in 
vivo, the chemoresponses noted in situ are appropriate.
Both levels o f  hypercapnia (7 and 9% CO 2) elicited a significant hypercapnic 
response in the in situ  preparation. Exposure to hypercapnia resulted in increases in 
neuroventilatory frequency in all experimental series. The 9% CO2 treatment induced 
augmentation o f  neural minute ventilation, although this was not observed with 7% CO2 
treatment. The observed decrease in burst peak amplitude associated with hypercapnia 
(7% CO2) present in the first series is perplexing. Although not a standard response, there 
are reports o f similar paradoxical responses to hypercapnia in rats that may be strain- 
specific (Hodges et al. 2002). This tendency dictated that neural minute ventilation would 
not increase w ith 7% CO2. In general, responses recorded in the current experiments are 
comparable to those observed in this preparation by other researchers (Day and Wilson
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2005, 2007; St-John and Paton 2000). These results are consistent with hypercapnic 
responses reported for decerebrate, vagotomized, otherwise intact animals, but are 
blunted compared to fully intact animals (as discussed above).
The contributions o f peripheral (carotid body-mediated) and central 
chemosensitivity have been determined in a variant o f  the in situ  preparation (the dual 
perfused preparation, in which the peripheral and central chemoreceptive areas are 
independently perfused) (Day and W ilson 2007). The levels o f  CO2 exposure normally 
used in this preparation (i.e. increasing CO2 in the perfusate from 5% to 7%) fall on a 
relatively insensitive region o f the CO2 response curve. We took this to explain the 
relatively mild changes in neural ventilation observed with changes in CO2 in our first 
series o f experiments and as justification for the levels o f CO2 exposure chosen in 
subsequent series (5% to 9% CO2).
Overall, our results illustrate that a significant and physiologically relevant 
neuroventilatory response occurs in our in situ  preparations. This observation allows us to 
determine if  5-HT neurons and serotonergic receptor activation are critical for this 
chemosensitivity.
2.4.2. Methysergide abolished the hypercapnic ventilatory response
M ethysergide maleate is a commonly used mixed 5-HT) and 5-HT2 receptor 
antagonist. Previous use o f this antagonist has produced varying effects on eupneic 
ventilation depending on the preparation type and experimental approach (Al-Zubaidy et 
al. 1996; Delpierre et al. 1994; Ptak et al. 2009; Toppin et al. 2007). One common 
influence o f methysergide treatment is a depression o f neural tidal volume, as illustrated 
in our results.
Our first series o f  experiments used this mixed receptor antagonist to determine if  
the 5-HT system plays a functional role in the hypercapnic neuroventilatory response in 
situ. Our results demonstrated that neuroventilatory responses to a CO2 challenge were 
abolished by methysergide application. Methysergide is recognized as a 5-HTi and 5 -HT2 
receptor antagonist (Hoyer et al. 1994). Our data suggest, therefore, that central 
chemosensitivity is critically dependent on 5-HTi and/or 5 -HT2 receptor activation. This
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supports the hypothesis that 5-HT neurons, and the release o f 5-HT, are necessary for 
central chemoreception.
2.4.3. 8-OH-DPATfacilitates neuroventilation
8-OH-DPAT is commonly used as a 5-H T ia receptor agonist, which binds to 
somatodendritic 5-H T ia receptors (autoreceptors). 5-H T iA receptors are coupled to 
inhibitory G-proteins, causing an inhibition o f adenylyl cyclase resulting in a decrease o f 
cyclic adenosine monophosphate (cAMP) levels (Richter et al. 2003). This decreases 
neuronal excitability and causes hyperpolarization through activation o f  inwardly 
rectifying potassium channels and inhibition o f N  and P/Q-type calcium channels 
(Ladewig et al. 2004). Thus, ligand binding to somatodendritic 5-H T ia receptors inhibits 
5-HT release (M cCall and Clement 1989; Sharp et al. 1989; Veasey et al. 1995).
8-OH-DPAT treatment in our in situ  preparation augmented phrenic burst 
discharge by increasing Ti and peak amplitude. Given the role o f  8-OH-DPAT in 
hyperpolarizing 5-HT neurons, our data suggest that 5-HT neurons limit Ti and peak 
amplitude during eupnea. Previous data from various animal preparations demonstrate 
conflicting results in ventilatory responses to 8-OH-DPAT, none o f which are entirely 
consistent with the current results. 5-HT[A agonism increases respiratory frequency in 
anesthetized adult rats and increases phrenic burst frequency in the reduced en bloc 
brainstem-spinal cord neonatal mouse preparation (Edwards et al. 1990; Hilaire et al. 
1997). W hether the differences between reported responses and our current observations 
are due to dose or system-specific factors remains to be determined. Regardless, the 
impacts o f 8-OH-DPAT on baseline activity in our preparation were not profound.
W hile the dom inant role o f 8-OH-DPAT is commonly assumed to be the silencing 
o f 5-HT neurons, effects o f  this agonist on receptors other than 5-H T ia autoreceptors 
should also be considered. Post-synaptic 5-H T iA receptors are found in several 
respiratory-related nuclei including the hypoglossal motor nuclei, the retrotrapezoid 
nucleus, and the preBotC (Liu and W ong-Riley 2009; Okabe et al. 1997). The role o f 
these post-synaptic 5-H T ia receptors in respiration, however, is difficult to determine. 
Results using mice in which central 5-HT neurons are absent (and thus the action o f 5-
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H T ia autoreceptors) suggest that activation o f  post-synaptic 5-H T iA receptors with 8- 
OH-DPAT facilitates breathing (Corcoran et al. 2009b). As these receptors are coupled to 
inhibitory G-proteins, the mechanism for the facilitation on the respiratory rhythm is 
unknown. However, the respiratory-related effects o f  8-OH-DPAT on post-synaptic 
receptors are more consistent with results reported in this study.
Additionally, 8-OH-DPAT has moderate affinity for 5-HT7 receptors (Bard et al. 
1993; Eriksson et al. 2008). While not traditionally found in respiratory nuclei, low levels 
o f mRNA expression for 5-HT7 receptors are found in the preBotC (Richter et al. 2003). 
Our knowledge o f  the role o f  5-HT7 receptors in breathing is very limited, although they 
do appear to be involved in restoring phrenic activity following a fentanyl-induced 
depression o f respiratory discharge (Richter et al. 2003). The potential facilitation o f 
respiration by activation o f 5-HT7 receptors could account for the increase in phrenic 
burst param eters that we observed. We speculate, therefore, that normocapnic responses 
to 8-OH-DPAT may reflect the actions o f this agonist on systems other than 5-H T iA 
autoreceptors.
2.4.3. The neuroventilatory response to hypercapnia is absent in the presence o f  8-OH- 
DPAT
Phrenic burst frequency did not respond to hypercapnia during systemic 
application o f  8-OH-DPAT, while it responded during control conditions. We interpret 
these data to suggest that central chemosensitivity is critically dependent on an 8-OH- 
DPAT-sensitive process. This agent attenuates 5-HT neuron activity through activation o f 
5-H T iA autoreceptors (M cCall and Clement 1989; Veasey et al. 1995). As such, these 
observations suggest that 5-HT neurons are critical for central chemosensitivity in our 
preparation. As discussed above, 8-OH-DPAT also impacts post-synaptic 5-H T iA and 5- 
HT7 receptors. Activation o f both o f these receptor subtypes appears to facilitate 
ventilation; thus a potential impact o f 8-OH-DPAT on post-synaptic 5-H T iA and 5-HT7 
receptors would not be expected to dampen hypercapnic sensitivity. We conclude, 
therefore, that these results most likely represent an inhibition o f  5-HT neurons, critical
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for chemosensitivity, through 5-H T1A autoreceptors. This result further supports the 
hypothesis that 5-HT neurons are necessary for central chemoreception.
Recent evidence suggests heterogeneity in medullary raphe chemoreception. 
While Li et al. (2006) showed that dialysis o f  8-OH-DPAT into particular sub-regions o f 
the medullary raphe (within pallidus and obscurus) has no significant effect on the CO2 
response in awake and sleeping rats, Taylor et al. (2005) found that a similar 
manipulation targeting a more caudal area o f the raphe (pallidus and magnus) attenuates 
the CO2 response. The purpose o f such experiments is to identify particular serotonergic 
nuclei involved in chemosensitivity, and potentially exclude others. Our experimental 
protocol involves more general activation o f 5-HTia receptors and is not designed to 
draw distinction between 5-HT neuron populations involved in the hypercapnic 
ventilatory response. We show, however, that the 5-HT system is critical in this reflex.
2.4.4. A ketanserin-sensitive mechanism is critical fo r  central chemosensitivity
We used ketanserin, a relatively specific 5 -HT2 antagonist, to identify the specific 
receptor subtype involved in the CO2 response in situ. This receptor subclass, which is 
coupled to G-proteins and through IP3- and DAG-inhibition o f  potassium channels 
induces neuronal excitability, and plays a critical role in respiratory-related rhythm 
generation and modulation in vitro (Pena and Ramirez 2002; Tryba et al. 2006).
However, we must be cautious when interpreting the importance o f 5-HT as a 
neuromodulator in vitro, as its role may be exaggerated in reduced preparations (Toppin 
et al. 2007). As such, ketanserin may have a different effect in situ  than in vitro.
Application o f ketanserin to the in situ  preparation had little effect on eupneic 
phrenic nerve discharge, indicating both a lack o f resting 5-HT2-mediated serotonergic 
tone and no critical reliance o f spontaneous eupneic patterns on 5 -HT2 receptor 
activation. 5-HT has been suggested to maintain stable breathing-related burst patterns in 
vitro (Pena and Ramirez 2002; Richter et al. 2003). Other studies, in more intact 
preparations, do not report a significant effect o f  5 -HT2 receptor inhibition on breathing 
in vivo (Dias et al. 2007) or on eupneic neuroventilation in situ  (Toppin et al. 2007). This 
discrepancy has been ascribed to a greater reliance on 5 -HT2 receptors in the generation
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o f stable repiratory-related discharge patterns in vitro , in the absence o f other endogenous 
neuromodulatory factors (Toppin et al. 2007).
Ketanserin had a much more significant effect on the response to elevated CO2. 
Addition o f  ketanserin to the aCSF abolished both the frequency and amplitude responses 
normally associated with an increase in CO2 in the in situ  preparation. This result 
illustrates that central chemosensitivity is critically dependent on a ketanserin-sensitive 
process. As this primary direct action o f ketanserin is as an antagonist blocking the post- 
synaptic 5 -HT2 receptors, we conclude that 5 -HT2 receptor activation is critical for 
central chemosensitivity in our preparation. Again, this result lends further support to the 
hypothesis that 5-HT neurons are necessary for central chemoreception.
The application o f ketanserin may have impacted not only 5 -HT2 receptors but 
also alpha-1 adrenergic receptors, as evidenced by its affinity for both receptors types 
(Hoyer et al. 1987). The disruption o f central chemosensitivity in our preparation, 
therefore, may have resulted from a dependence o f chemosensitivity on alpha-1 
adrenergic receptors activation. However, as the primary outcome o f  the ketanserin 
treatment was similar to that o f methysergide and 8-OH-DPAT (which do not target 
adrenergic receptors), the most parsimonious conclusion is that the resulting changes in 
the ventilatory hypercapnic response due to ketanserin were prim arily due to inhibition o f 
5 -HT2 receptors rather than effects on the adrenergic system. This has been observed 
regarding ketanserin’s hypotensive effect, where alpha-adrenergic blockade makes a 
minimal contribution compared to the serotonergic system (Naslund et al. 1988).
Ketanserin may also have some affinity for 5-HT7 and histamine HI receptors 
(Jasper et al. 1997; Shen et al. 1993; Wouters et al. 1985). Histamine plays a 
neuromodulatory role in breathing, with agonism o f H I receptors increasing phrenic burst 
frequency, and antagonists decreasing both frequency and burst amplitude (Dutschmann 
et al. 2003). We did not observe an effect o f ketanserin on the eupneic phrenic burst 
frequency or amplitude in our preparations and therefore find it unlikely that ketanserin- 
induced antagonism o f H I or 5-HT7 receptors greatly affected our results.
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2.4.5. Controversy o f  the role o f  5-HT neurons in hypercapnic sensitivity
Recently, the role o f  5-HT neurons in the central response to CO2 has been 
challenged (Guyenet 2008; Mulkey et al. 2004). In a recent review, we have disputed 
these arguments (Corcoran et al. 2009a). Prior to the present study, a weakness in the 
argument that 5-HT neurons function as chemosensors has been a lack o f  confirmation 
that 5-HT neuron-mediated processes are critical to ventilatory response to CO2 in a 
relatively intact, non-anesthetized animal. Our present results provide further evidence 
that 5-HT neurons and 5-HT receptor activation are indeed important in the hypercapnic 
neuroventilatory response.
2.4.6. Conclusions
Our data demonstrated that, in an unanesthetized, decerebrate, and arterially 
perfused in situ  preparation, administration o f  methysergide, 8-OH-DPAT, and ketanserin 
all prevented the neuroventilatory responses associated with hypercapnia. The feature 
unifying the pharmacological action o f  the three agents tested is an impact on 
serotonergic neurotransmission. Methysergide impacts 5-HTi and 5-HT2 receptors; 8- 
OH-DPAT activates 5-H TiA receptors, attenuating 5-HT neuron activity; and ketanserin 
blocks post-synaptic 5-HT2 receptors. Taken together, our data suggest that activation o f 
5-HT neurons, releasing 5-HT as a neurotransm itter with impacts on post-syanptic 5 -HT2 
receptors is critical for normal chemosensitivity. Our results are consistent with the 
growing pool o f data suggesting that serotonin neurons, particularly those o f the 
medullary raphe, play a large role in central chemoreception (Corcoran et al. 2009a; Dias 
et al. 2007; Hodges et al. 2008).
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Figure 2.1 Phrenic nerve responses to hypercapnia without (untreated) and with exposure to 
methysergide (5-10 pM). Data are means ± SE of hypercapnic values expressed as a percentage 
of normocapnic control values. Significant differences from baseline are denoted by an asterisk 
(*) and a number sign (#) indicates a significant difference between untreated and treated groups 
(n = 4 for untreated and n = 8  for methysergide, two-way ANOVA, P < 0.05).
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Figure 2.2 Effect of hypercapnia on neural correlates of minute ventilation (phrenic burst 
frequency x burst amplitude) before and during pharmacological manipulation of the serotonergic 
system. Data are means ± SE of hypercapnic values expressed as a percentage of normocapnic 
control values. Significant differences from baseline are denoted by an asterisk (*) and a number 
sign (#) indicates a significant difference between untreated and treated groups (two-way RM 
ANOVA, P < 0.05).
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Figure 2.3 Effect of serotonergic antagonists and agonists on phrenic burst parameters in the in 
situ preparation. Data are means ± SE of burst parameter values during pharmacological 
administration expressed as a percentage of eupneic values. Significant differences from baseline 
are denoted by an asterisk (*) (paired t-test, P < 0.05).
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Figure 2.4 Phrenic nerve responses to hypercapnia without (untreated) and with exposure to 8- 
OH-DPAT (1.5 pM). Data are means ± SE of hypercapnic values expressed as a percentage of 
normocapnic control values. Significant differences from baseline are denoted by an asterisk (*) 
(,n = 6; two-way RM ANOVA, P < 0.05).
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Figure 2.5 Phrenic nerve responses to hypercapnia without (untreated) and with exposure to 
ketanserin (5 pM). Data are means ± SE of hypercapnic values expressed as a percentage of 
normocapnic control values. Significant differences from baseline are denoted by an asterisk (*) 
and a number sign (#) indicates a significant difference between untreated and treated groups (n = 
8; two-way RM ANOVA, P < 0.05).
Table 2.1 Phrenic nerve frequency response to hypercapnia with and without 5-HT impairment
Treatment group
Phrenic burst frequency (m in '1)
n
control
normocapnia hypercapnia*
with treatment 
normocapnia hypercapnia*
Methysergide** control group 4 22.3 ± 1.1 28.9 ±2 .1 . .
drug group 8 21 .4±  1.3 — 34.6 ± 2 .5 34.6 ± 1.9
8-OH-DPAT 6 38.3 ± 4 .2 41.5 ± 3.1 40.6 ± 1.9 41.4 ± 2 .9
Ketanserin 8 27.3 ± 2.2 29.8 ± 1.8 30.3 ± 2 .5 29.5 ± 2.7
Values are mean ± SE
* Methysergide preparations were exposed to 7% C02, and 8-OH-DPAT and ketanserin preparations to 9% CO2 
** Non-repeated design
Table 2.2 Phrenic nerve burst duration (T\) response to hypercapnia with and without 5-HT impairment
Treatment group
Phrenic burst duration (sec)
n
control
normocapnia hypercapnia*
with treatment 
normocapnia hypercapnia*
Methysergide** control group 4 0.59 ± 0 .0 7 0.59 ±0.1
drug group 8 0.47 ± 0.02 — 0.45 ± 0.02 0.48 ± 0 .07
8-OH-DPAT 6 0.44 ± 0.03 0.43 ± 0.02 0.49 ± 0.02 0.53 ±0 .03
Ketanserin 8 0.40 ± 0.02 0.42 ± 0.02 0.47 ± 0.04 0.51 ± 0 .05
Values are mean ± SE
* Methysergide preparations were exposed to 7% CO2 and 8-OH-DPAT and ketanserin preparations to 9% CO2 
** Non-repeated design
Table 2.3 Phrenic nerve inter-burst interval (Te)  response to hypercapnia with and without 5-HT impairment
Treatment group
Phrenic inter-burst interval (sec)
n
control
normocapnia hypercapnia*
with treatment 
normocapnia hypercapnia*
Methysergide** control group 4 2.32 ±0 .08 1.72 ± 0 .0 7 __ _
drug group 8 2.50 ± 0 .17 — 1.43 ± 0 .12 1.51± 0.10
8-OH-DPAT 6 1.28 ± 0 .2 7 1.07 ±0.15 1.01 ± 0 .09 0.97 ± 0 .1 0
Ketanserin 8 1.89 ± 0.18 1.64 ± 0 .12 1.62 ± 0 .19 1.66 ± 0 .1 9
Values are mean ± SE
* Methysergide preparations were exposed to 7% CO2, and 8-OH-DPAT and ketanserin preparations to 9% CO2 
** Non-repeated design
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Chapter 3 Modulation of respiratory activity by hypocretin-1 (orexin A) in 
situ and in vitro1
Abstract
Release o f  hypocretins (orexins) by neurons in the lateral hypothalamus is an 
contributes importantly to arousal state, thermoregulation, and feeding behavior. 
Hypocretin neuromodulation has recently been proposed to play a role in breathing and 
central chemosensitivity. Using the in situ  arterially perfused juvenile rat preparation, we 
determined the effect o f hypocretin-1 (hcrt-1) and SB-408124 (an antagonist for 
hypocretin receptor subtype 1 , hcrt-rl) on phrenic nerve activity, a neural correlate o f 
breathing (neuroventilation), and on the neuroventilatory sensitivity to CO 2. Application 
o f hcrt-1 through the perfusate had little effect on baseline firing. Blocking hcrt-rl, 
however, prevented the phrenic burst frequency response normally associated with 
hypercapnia. These data suggest that endogenous hypocretinergic modulation enhances 
neuroventilatory chemosensitivity. Further studies using the in vitro medullary slice 
preparation explored the effect o f hcrt- 1 on hypoglossal nerve activity, a correlate o f 
ventilation in vitro. Application o f exogenous hcrt-1 failed to significantly alter 
hypoglossal burst output in neonatal rat slices, indicating that this portion o f  the 
neuroventilatory circuit is insensitive to hcrt-1. Taken together, these data suggest that 
hcrt- 1 is a m odulator o f central chemosensitivity.
3.1. Introduction
Hypothalamic neuropeptides hypocretin-1 (orexin A) and -2 (orexin B) are 
synthesized in cells o f  the lateral hypothalamus that project widely throughout the brain
1 Corcoran AE, Richerson GB, and Harris MB. 2009. Modulation o f  respiratory activity by hypocretin-1 
(orexin A) in situ  and in vitro. Submitted to a Special Issue o f  Advances in Experimental Medicine and 
Biology.
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(Peyron et al. 1998). Their extensive homeostatic roles include maintenance o f arousal 
state, thermoregulation, and contributions to feeding behavior (Sakurai et al. 1998). 
Additionally, both anatomical and functional evidence suggests that endogenous 
hypocretins modulate breathing. Axons o f orexin-containing neurons project to 
respiratory-related nuclei including the nucleus tractus solitarius (NTS), preBotzinger 
Complex (preBotC), and hypoglossal and phrenic nuclei, as well as central 
chemoreceptor areas such as the raphe nuclei (Fung et al. 2001; N akam ura et al. 2007; 
Peyron et al. 1998). The preBotC and the phrenic motor nuclei are immunoreactive for 
hypocretin receptor 1 (hcrt-rl) (Young et al. 2005), while hypocretin receptor 2 (hcrt-r2) 
is expressed in hypoglossal motoneurons (Volgin et al. 2002). Physiological evidence 
also indicates that hypocretins affect ventilation. Injection o f  hypocretin-1 into the lateral 
ventricle o f  urethane-anesthetized mice results in a small increase in breathing frequency 
(-11% ) and a larger increase in tidal volume (-75% ) (Zhang et al. 2005). Administration 
o f hypocretin-1 into the preBotC in vivo increases diaphragmatic electromyogram activity 
but does not affect breathing frequency (Young et al. 2005). These results suggest that 
hypocretin stimulates respiration primarily through increases in tidal volume. Nakamura 
et al. (2007) looked at the respiratory phenotype o f  a prepro-orexin knockout mouse 
(which lacks both hypocretin-1 and -2). Frequency and tidal volume showed sleep-wake 
dependency in both wildtype and knockout mice; however, no significant differences in 
minute ventilation occur between the two phenotypes.
Three lines o f evidence establish correlation between the hypocretinergic system 
and the hypercapnic chemoreflex. Hypocretin neurons themselves are chemosensitive in 
vitro (Sunanaga et al. 2009; W illiams et al. 2007). Although ventilatory responses to 
hypercapnia do not differ between wildtype and prepro-orexin knockout mice during 
sleep states, these responses are blunted in knockouts during wakefulness (Nakamura et 
al. 2007). Antagonism o f hcrt-rl in the retrotrapezoid nucleus (RTN) blunts the response 
to hypercapnia, predominantly in wakefulness (Dias et al. 2009).
The aim o f the current study was to identify the role o f the hypocretinergic system 
in neuroventilation and the hypercapnic neuroventilatory response. Using the in situ
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preparation, we identified the effects o f  hypocretin - 1  administration and o f  hcrt-rl 
antagonism on phrenic neuroventilation, and on changes in neuroventilation with 
hypercapnia (chemosensitivity). We also identified the effects o f  hypocretin-1 on the 
hypoglossal nerve output in a neonatal rat rhythmic medullary slice preparation. We 
tested the hypothesis that exognenous hypocretin - 1 stimulates neuroventilation and 
enhances chemosensitivity, while antagonism o f hcrt-rl dampens neuro ventilation and 
blunts chemosensitivity.
3.2. M ethods
3.2.1. Arterially perfused in situ preparation
Experiments were performed on arterially perfused in situ  preparations derived 
from juvenile (post-natal day 26-30; 60-100 g) male Sprague-Dawley rats. Details o f this 
procedure have been published previously (Corcoran 2009; Paton 1996; Toppin et al.
2007). After one hour o f baseline recording during perfusion with an artificial 
cerebrospinal fluid (aCSF; composed of, in mM: 1.0 M gS0 4 , 0.25 KH 2PO4, 4.0 KC1, 25 
NaHCC>3, 115 NaCl, 2.0 CaCh, 10 dextrose, and 0.1785 Ficoll 70) equilibrated with 5% 
CO2 balanced with 95% O2 (normocapnia), CO2 in the perfusate was increased to 10 % for 
5 minutes (hypercapnia). A comparison o f the phrenic burst parameters recorded during 
hypercapnia relative to normocapnia illustrated the normal neuroventilatory response to 
hypercapnia. The perfusate was then re-equilibrated with 5% CO2. Either hypocretin-1 (3 
and 30 nM final concentration in aCSF; targets both hcrt-lr and hcrt-2r), SB-408124 (3 
pM in aCSF, hcrt-rl antagonist), or aCSF alone (sham treatment), was then used to 
perfuse the animal for 5 minutes prior to a second hypercapnic challenge completed in 
the presence o f  the pharmacological agent or sham. Differences in the response to 
hypercapnia were compared between the drug and control aCSF.
We attempted to determine the interaction between effects o f hypercapnia and 
pharmacological modulation using a two-way repeated measures ANOVA; however, the 
data were not normally distributed, invalidating a critical assumption o f  this test, and 
precluding assessment in this manner. Statistical significance o f  the difference between
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hypercapnia and baseline (either with or without pharmacological disruption) was 
resolved using Student’s paired t-tests. Data presented are means ± SE. The criterion 
level for determination o f statistical significance was set at P < 0.05.
3.2.2. In vitro medullary slice preparation
Experiments were performed on brainstem slices prepared from neonatal rats 
(post-natal day 0-4). Rats were decapitated, and the brainstem and spinal cord removed 
under a flow o f chilled dissection solution composed of, in mM: 124 NaCl, 25 NaHCC>3,
3 KC1, 1.5 CaCh, 1.0 MgSC>4, 0.5 NaH2P0 4 , 30 D-glucose, and equilibrated with 95% O2 
and 5% CO2 (pH -7 .4 ). The brainstem was pinned to a wax block, and transverse slices 
o f the medulla (550-650 pm  thick) were prepared using a vibratome (see Smith et al.
1991 for details). Slices containing the preBotC, the hypoglossal motor nuclei, and the 
most rostral hypoglossal nerve rootlets were placed in a recording cham ber (0.7 ml) and 
superfused with recording solution (dissection solution with elevated potassium) at a rate 
o f  1.0 ml/minute via a syringe pump (Harvard Apparatus). The aCSF was warmed to 
29°C using a temperature controller (W arner Instruments; TC-324B). Potassium 
concentrations were elevated in recording solutions (to 8 mM ) to ensure rhythmic activity 
in the slice, as per standard procedures (Smith et al. 1991).
Inspiratory-related motor discharge o f  the hypoglossal rootlets was recorded 
continuously by glass suction electrodes. Signals were amplified x 10,000 and band-pass 
filtered (0.3 -  1 kHz) using a Grass LP511 AC amplifier and Dagan EX4-400 differential 
amplifier. A Hum Bug noise eliminator (Quest Scientific) was used to filter 60 Hz 
activity. Data were digitized at 100 kHz and analyzed off-line using M atlab software 
(MathWorks). Analysis o f  hypoglossal root discharge included an initial integration; full 
wave rectification and moving average over 50-msec periods.
After 30 minutes o f baseline recording, the superfusate was switched to one 
containing hypocretin-1 (30 and 300 nM) and applied continuously to the slice for 10 
minutes. Recordings during the last two minutes o f  hypocretin-1 application were used to 
determine the effect o f the drug relative to baseline. Statistical significance was
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determined using Student’s paired t-tests. Data are presented as means ± SE. The 
criterion level for determination o f statistical significance was set at P  < 0.05.
3.3. Results
3.3.1. Effect o f  exogenous hypocretin-1 and hypocretin receptor antagonism on 
phrenic nerve activity
Neither dose o f  hypocretin-1 in the arterially perfused in situ  preparation 
significantly altered baseline phrenic burst frequency nor the inter-burst interval (T e) 
(Table 3.1; 3.2). The only effect observed was an increase in burst duration (Ti) following 
administration o f  30 nM  hypocretin-1 (increase from 0.48 ± 0.06 to 0.55 ± 0.06 seconds; 
Table 3.3). Exogenous hypocretin-1 did not affect burst amplitude.
Blockade o f  endogenous hypocretin on hcrt-rl by SB-408124 (3 pM) 
significantly increased burst frequency (increase from 31.4 ± 2.0 to 33.9 ± 2.0 
bursts/minute; Table 3.1). The increase in frequency was mediated by a decrease in Te 
(decrease from 1.47 ± 0.09 to 1.33 ± 0.09 seconds), while no change in Ti was observed 
(Table 3.2; 3.3). SB-408124 did not alter baseline phrenic burst amplitude (not shown).
3.3.2. Effect o f  hypocretin-1 and hypocretin receptor antagonism on the 
neuroventilatory hypercapnic response
Increasing CO2 in the perfusate significantly increased burst frequency in both 
control and treatm ent conditions (27 ± 4% increase from baseline in control; 16 ± 6% and 
21 ± 4 % increases with 3 nM and 30 nM hypocretin-1, respectively; n = 6 for each dose; 
Fig. 3.1). This response was mediated by a decrease in Te in each case (Fig. 3. IB). In all 
cases, hypercapnia did not alter burst amplitude or Ti (Fig. 3 .IB).
A m odest phrenic burst frequency response to hypercapnia was observed in the 
control group associated with SB-408124 treatment experiments (12 ± 4% increase from 
baseline, during control conditions; n = 8; Fig. 3.2). Te was significantly decreased in 
response to hypercapnia in the absence o f hcrt-rl antagonists, while Ti was not altered.
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Phrenic burst parameters or burst frequency did not change in response to hypercapnia 
once the hcrt-rl antagonist was added (Fig. 3.2).
3.3.3. Effect o f  exogenous hypocretin-1 on hypoglossal nerve activity
Although there was substantial inter-slice variability, the hypoglossal burst 
activity o f  neonatal rat rhythmic medullary slices was unchanged by exogenous hcrt- 1  
treatment (Fig. 3.3). Hypoglossal burst frequency was not significantly different when 
exposed to 30 nM hypocretin-1 (from 5.7 ± 0.4 bursts/minute at baseline to 5.0 ± 0.4 
bursts/minute with 30 nM hypocretin-1, n = 10). Similarly, exposure to 300 nM 
hypocretin-1 did not alter burst frequency (from 6.6 ± 0.9 bursts/minute at baseline to 5.5 
± 0.8 bursts/minute with 300 nM hypocretin-1, n = 9). Burst duration was not altered in 
response to either dose o f hypocretin (30 or 300 nM: in seconds, 0.92 ± 0.05, 0.85 ± 0.08, 
baseline; 0.82 ± 0.06, 0.97 ± 0.07, treatment, respectively).
3.4. Discussion
3.4.1. Hypocretin and neuroventilation
Our data indicated that exogenous hypocretin had limited impact on 
neuroventilation in situ  and no impact in vitro. Neither dose o f  hypocretin administered 
in situ  had significant effect on baseline phrenic burst frequency. Similarly, hypocretin 
application in the in vitro rhythmic medullary slice had no effect on hypoglossal burst 
frequency. We interpret this lack o f response to indicate that hypocretin had little to no 
impact on baseline neuroventilation, that hypocretin administered via systemic perfusate 
(in situ) was restricted from action within the central nervous system, or that sufficient 
endogenous hypocretin was present in the preparations such that addition o f exogenous 
hypocretin had no impact.
The absence o f  a phrenic burst frequency response to exogenous hypocretin is 
consistent with some o f the existing, albeit limited, literature. There is an anatomical 
basis for potential hypocretin-mediated alteration o f respiratory rhythm as hypocretin- 
containing neurons project to the putative respiratory rhythm generator, the preBotC, and
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hypocretin receptors are found on preBotC neurons (Young et al. 2005). Thus the 
anatomical potential for alteration o f the respiratory rhythm is present. The reported 
effect o f hypocretins on breathing frequency, however, is not consistent within the 
literature. Depending on the experimental design, hypocretins have little, if  any, effect on 
breathing frequency. In vivo injection o f exogenous hypocretin moderately increases 
breathing frequency (Zhang et al. 2005). However, direct application o f exogenous 
hypocretin to the preBotC does not affect phrenic burst frequency (Young et al. 2005). In 
addition, mice with a genetically induced absence o f endogenous hypocretin have similar 
breathing frequencies to wildtype mice (Nakamura et al. 2007).
The increase in phrenic burst frequency observed in response to SB-408124 is 
curious as it presumably resulted from blockade o f  endogenous hypocretin actions on 
hcrt-rl. The mechanism for such an effect is unknown, and it is not consistent with 
previous characterized actions o f hypocretin on breathing frequency. This observation 
possibly reflects an unknown nonspecific action o f  SB-408124.
The primary modulation o f ventilation by hypocretins is proposed to be through 
changes in tidal volume (Young et al. 2005; Zhang et al. 2005). Hypocretin receptors are 
found in phrenic m otoneuron pools and hypocretinergic axons project to the phrenic 
nuclei (Fung et al. 2001; Young et al. 2005). We found no effect o f exogenous hypocretin 
nor blockade o f  endogenous hypocretin on phrenic burst amplitude, a correlate o f tidal 
volume (Eldridge 1971). The high dose o f exogenous hypocretin (30 nM) used in the in 
situ  preparation, however, increased burst duration. Burst duration correlates to the time 
devoted to inspiration, as phrenic nerve activity transmits to an inspiratory movement o f 
the chest cavity through contraction o f the diaphragm. An increase in inspiratory period, 
with exogenous hypocretin, would enhance inspiration and augment ventilation.
One factor potentially contributing to a lack o f  effects o f  hypocretinergic 
modulation (either by exogenous hypocretin, or by inhibition o f hypocretin receptors) 
may be related to the circadian cycling o f hypocretin. Hypocretin levels in the 
cerebrospinal fluid exhibit a circadian rhythm; levels o f hypocretin - 1  are high during 
wake and active periods, and low during sleep periods (Desamaud et al. 2004). We do not
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know the equivalent o f arousal state in the in situ  preparation, nor o f the in vitro 
medullary slice preparation. It may be that the phase o f the circadian cycle from which 
animals were taken could influence hypocretinergic responses o f  the in situ  or in vitro 
preparations. A lthough we did no control for circadian cycle, individual responses did not 
appear to depend on the time o f experiment (data not shown).
3.4.3. Effect o f  hypocretin receptor blockade on the hypercapnic neuroventilatory 
response
We hypothesized that since hypocretin appears to contribute to the hypercapnic 
ventilatory response (Dias et al. 2009; Nakamura et al. 2007), addition o f  hypocretin-1 
could enhance the response seen in situ, and blockade o f endogenous hypocretin using 
hcrt-rl antagonists would blunt the response. We found that neuroventilatory sensitivity 
to CO2 was not enhanced by exogenous hypocretin in the in situ  preparation. Again, this 
suggests either that hypocretin was not involved with in situ  chemoresponsiveness, or 
that endogenous hypocretin was sufficient. Since there was a neuroventilatory response to 
hypercapnia in the absence o f a hcrt-rl antagonist and there was no response in the 
presence o f a hcrt- 1 antagonist, we interpret the data to suggest that endogenous 
activation o f the hypocretinergic system contributed to the ventilatory response to 
hypercapnia (though we were not able to statistically compare both responses).
Hypothalamic hypocretin-producing neurons are characterized as chemosensitive 
in vitro (W illiams et al. 2007). Our data suggest, however, that hypocretin was not acting 
directly as a neurotransm itter transducing a chemosensory signal and activating 
respiratory control nuclei in our system. If  C0 2 -sensitive hypocretin neurons were 
responsible for hypercapnic neuroventilatory responses, through the release o f hypocretin 
on respiratory-related nuclei, we would expect that exogenous hypocretin application in 
normocapnia would at least, in part, mimic neuroventilatory responses to hypercapnia. 
This was not the case. W e postulate that the sensitivity and/or integration o f central 
chemoreceptors is modulated by hypocretin, that endogenous hypocretin is sufficient to 
facilitate maximal sensitivity, and that it enhances normal sensitivity and/or integration o f 
central chemoreceptors. Recently, hypocretin has been shown to contribute to
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chemosensory integration within the RTN (Dias et al. 2009). Our data support a model 
where endogenous hypocretin facilitates central chemosensitivity in wakefulness, and 
disfacilitation associated with reduced hypocretin neuron activation during sleep reduces 
ventilatory chemosensitivity, and is normally associated with transitions from 
wakefulness to sleep (Estabrooke et al. 2001; Lee et al. 2005; Phillipson et al. 1977). 
Essential facilitation o f chemosensitivity by hypocretin may also explain the relatively 
low sensitivity o f putative chemosensitive neurons and circuits studied in vitro. We 
speculate that in the absence o f critical endogenous hypocretin facilitation, in vitro 
systems exhibit reduced chemosensitivity when compared to greater chemosensitivity 
exhibited by more intact systems.
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Figure 3.1 Effect of hypocretin-1 on the phrenic neuroventilatory response to hypercapnia in the 
perfused in situ rat preparation. A) Integrated traces at normocapnia and hypercapnia, before and 
during exposure to 30 nM hypocretin-1. B) Data are mean values ± SE expressed as a percentage 
of normocapnic control values before (white hatched bars), and after (grey hatched bars) 
administration of hypocretin-1 (3 nM and 30 nM; n = 6 for each dose). Significant differences 
from normocapnic baseline are denoted by * (paired t-test, P < 0.05). Abbreviations include: T], 
inspiratory time (burst duration); TE, expiratory time (inter-burst interval).
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Figure 3.2 Effect of a hcrt-rl antagonist (SB-408124) on the phrenic neuroventilatory response to 
hypercapnia in the perfused in situ rat preparation. Data are mean values ± SE expressed as a 
percentage of normocapnic control values before (white hatched bars), and after (grey hatched 
bars) administration of SB-408124 (3 pM; n = 8). Significant differences from normocapnic 
baseline are denoted by * (paired t-test, P < 0.05). Abbreviations include: Ti, inspiratory time 
(burst duration); Te, expiratory time (inter-burst interval).
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Figure 3.3 Effects of application of exogenous hypocretin-1 in neonatal rat medullary slice 
preparations. Shown are mean changes in burst frequency, amplitude, and duration in response to 
hypocretin-1(30 and 300 nM; n = 10 and 9, respectively). Data are mean values ± SE expressed 
as a percentage of normocapnic control values. Circles represent individual data points.
Table 3.1 Phrenic nerve frequency response to hypocretinergic modulation
during normocapnia
Treatment group Dose
Phrenic burst frequency (m in '1)
n Control W ith treatment
hypocretin-1 3 nM 6 29.8 ± 0 .7 30.8 ± 1.2
30 nM 6 33.8 ± 5.3 31.5 ± 4 .2
SB-408124 3 pM 8 31.4 ± 2.0 33.9 ±2 .0*
Values are mean ± SE
* indicates significant difference from control (paired t-test, P  < 0.05)
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Table 3.2 Phrenic nerve burst duration (T\) response to hypocretinergic 
modulation during normocapnia
Treatment group Dose
Phrenic burst duration (sec)
n Control W ith treatment
hypocretin-1 3 nM 6 0.43 ± 0 .02 0.43 ± 0 .03
30 nM 6 0.48 ± 0 .0 6 0.55 ±0.06*
SB-408124 3 pM 8 0.49 ± 0 .0 4 0.49 ± 0 .03
Values are mean ± SE
* indicates significant difference from control (paired t-test, P  < 0.05)
Table 3.3 Phrenic nerve inter-burst interval (Te)  response to hypocretinergic
modulation during normocapnia
Treatment group Dose
Phrenic inter-burst interval (sec)
n Control W ith treatment
hypocretin - 1 3 nM 6 1.59 ± 0 .0 4 1.53 ± 0 .0 6
30 nM 6 1.54 ± 0 .3 0 1.52 ± 0 .23
SB-408124 3 pM 8 1.47 ± 0 .0 9 1.33 ±0 .09*
Values are mean ± SEM
* indicates significant difference from control (paired t-test, P < 0.05)
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Chapter 4 Functional link between the hypocretinergic and serotonergic 
systems in neuroventilation and central chemosensitivity1
Abstract
Serotonergic (5-HT) cells o f the medullary raphe are putative central chemoreceptors, 
proposed to be one o f multiple chemoreceptive sites in the brainstem interacting to 
produce the respiratory chemoreflex. Hypocretinergic neurons o f the lateral 
hypothalamus, which are important contributors to arousal state, thermoregulation, and 
feeding behavior, are also reportedly involved in the hypercapnic ventilatory response. 
Recently, a functional interaction has been found between the hypocretinergic system and 
5-HT neurons o f  the dorsal raphe. The validity and potential functional significance o f 
hypocretinergic modulation o f medullary raphe 5-HT neurons, however, is unknown. As 
such, the purpose o f this study was to explore functional interactions between the 
hypocretinergic system and 5-HT system o f the medullary raphe on both baseline 
respiratory-related output and central chemosensitivity. To explore such interactions, we 
took advantage o f  the in vitro medullary slice preparation derived from both wildtype 
(normal 5-HT function) and L m x l 0 /p neonatal knockout mice (lack all central 5-HT 
neurons) and exam ined effects o f acidosis, hypocretin-1 , hypocretin receptor antagonists 
(SB-334867, SB-408124, TCS 0X 2  29), and the effect o f  these antagonists on the 
response to acidosis. We confirmed the critical role o f 5-HT neurons in central 
chemosensitivity as L m x l 0 /p preparations did not exhibit a response to acidosis, while 
wildtype increased hypoglossal burst frequency. We also found that hypocretins 
facilitated baseline neural ventilatory output in part through 5-HT neurons. While the 
impact o f  hypocretin on 5-HT neuronal sensitivity to acidosis is still in question, 
hypocretins did appear to mediate the burst duration response to acidosis via serotonergic 
mechanisms.
1 Corcoran AE, Richerson GB, and Harris MB. 2009. Functional link between the hypocretinergic and 
serotonergic systems in neuroventilation and central chemosensitivity. Prepared for submission to the 
Journal of Neurophysiology.
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4.1. Introduction
Currently a growing body o f literature suggests that serotonergic (5-HT) cells o f 
the medullary raphe are an important chemoreceptive site in the brainstem (see Corcoran 
et al. 2009a and Richerson 2004 for review). Recent investigation into the importance o f 
the 5-HT system in ventilatory chemosensitivity has exploited the use o f a transgenic 
mouse in which a critical transcription factor {Lm xlb) is conditionally and selectively 
knocked out in all 5-HT cells in the central nervous system. This results in a near- 
complete (>99%) and specific absence o f  central serotonergic neurons as well as a 
coincident marked depletion o f  central 5-HT in the homozygote transgenic (Ding et al. 
2003; Zhao et al. 2006). This L m xlt/^ /p mouse is an invaluable tool as it enables us to 
focus more specifically on the role o f 5-HT versus non-5-HT neurons in central 
chemosensitivity. As adults, L m xlb  knockouts breathe normally (albeit slightly slower) at 
rest, but they display a blunted ventilatory response to hypercapnia (about 50% less than 
wildtype mice) and abnormal thermoregulatory responses (Hodges et al. 2008). However, 
their response to elevated CO2 as neonates has not been reported. W hile it is postulated 
that 5-HT neurons do not exhibit chemosensitivity in cell culture and slice until P I 2, 
chemosensitivity o f these neurons may be altered in a rhythmic medullary slice 
preparation, derived from such neonatal mice, in response to a large change in pH. The 
present study is designed to illustrate the chemosensitivity mediated by neonatal 5-HT 
neurons, by quantifying the chemosensitivity o f rhythmic slice preparations derived from 
mice with and without 5-HT neurons.
As more nuclei and areas are found to play a role in the respiratory chemoreflex, 
chemosensitivity is hypothesized as a distributed network function involving multiple 
chemoreceptive sites in the brainstem (Nattie and Li 2009). Progress is now being made 
to identify how  these different chemoreceptive sites interact and modulate each other 
and/or the respiratory rhythm itself (Dias et al. 2008, 2009; Li et al. 2006; Mulkey et al. 
2007).
A role for hypocretins in CO2 sensitivity is a recently proposed idea (Dias et al. 
2009; Nakamura et al. 2007). These neuropeptides, themselves recently discovered, are
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synthesized by neurons in the lateral hypothalamus (Peyron et al. 1998; Sakurai et al.
1998). Hypocretin-1 (orexin A) and hypocretin-2 (orexin B) target two G-protein-coupled 
receptors; hypocretin receptor 1 (hcrt-rl) and hypocretin receptor 2 (hcrt-r2) (Sakurai et 
al. 1998). While hcrt-rl is coupled to an excitatory G-protein, hcrt-r2 is coupled to either 
an excitatory or an inhibitory G-protein (Beuckmann and Yanagisawa 2002). The 
hypocretinergic system is anatomically linked with central respiratory nuclei as well as 
putative chemoreceptive sites (Fung et al. 2001; Hagan et al. 1999; Nakam ura et al. 2007; 
Volgin et al. 2002; Young et al. 2005). The functional consequences o f  such interactions 
and the specific effects on ventilation remain unclear (Corcoran 2009; Nakamura et al. 
2007; Young et al. 2005; Zhang et al. 2005). The emerging role o f hypocretins in 
modulating the hypercapnic ventilatory response appears to be arousal-state dependent. 
Nakamura et al. (2007) shoed that while the response to inhaled hypercapnia is similar 
during sleep, CO2 responses during wakefulness are blunted in hypocretin knockout mice 
compared to wildtype. This would suggest that hypocretins facilitate hypercapnic 
sensitivity specifically during the awake state. A link between hypocretins and 
chemoreception is also found in the retrotrapezoid nucleus (RTN), illustrated by a state- 
dependent effect o f hypocretins on the hypercapnic ventilatory response; antagonism o f 
hcrt-rl in the RTN blunts the response to hypercapnia predominantly in wakefulness 
(Dias et al. 2009).
Similar potential interactions between the hypocretinergic system and the 
medullary raphe have not yet been explored. To date, most o f  the physiological evidence 
linking the hypocretinergic system with the 5-HT system has focused on the dorsal raphe 
and the regulation o f  sleep and wakefulness (hypocretin-1 excites 5-HT dorsal raphe 
neurons both in brainstem slices and in vivo; Brown et al. 2001; Takahashi et al. 2005). 
However, since hypocretin receptors 1 and 2 are also present in the medullary raphe, and 
projections o f  hypocretin neurons terminate in that area, it is possible that this system 
interacts with the medullary 5-HT system to promote a response to hypercapnia (Marcus 
et al. 2001; Nambu et al. 1999; Zheng et al. 2005).
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The aims o f the present studies were two fold. The first aim was to test the 
hypothesis that 5-HT neurons contribute to the neuro ventilatory response to low pH in an 
in vitro rhythmic medullary slice preparation. To do this, we compared responses to 
acidosis in slice preparations derived from wildtype (containing 5-HT neurons) and 
L m xlt/^ /p (lacking central 5-HT neurons) mouse strains. The second aim was to establish 
that hypocretinergic modulation o f neuroventilation and chemosensitivity is determined 
by an impact o f hypocretin on 5-HT neurons. We tested the hypothesis that hypocretins 
contribute to neuroventilation and promote the neuroventilatory response to acidosis 
through 5-HT neurons. To do this, we identified whether hypoglossal nerve activity 
changes generated by hypocretin - 1  and hypocretin receptor antagonists depended on the 
presence o f 5-HT neurons. We also identified the effects o f  hypocretin receptor 
antagonism on hypoglossal nerve responses to acidosis and whether or not this was 
dependent on the presence o f 5-HT neurons.
4.2. M ethods
All procedures and protocols were approved by the Institutional Animal Care and 
Use Committees o f  Yale University, where this research was conducted.
4.2.1. Animal model
The generation o f L m x lt/^ /p mice has been previously described by Zhao et al. 
(2006). Briefly, the breeding strategy involves mating females homozygous for floxed 
L m xlb  (L m x ll/^) with males homozygous for floxed L m xlb  and hemizygous for eP etl-  
Cre (L m x lt/lox/-flox'ePel'Cre/+, also referred to as Lm xlb//f/p) to create offspring that lack both 
L m xlb  alleles specifically in Petl-C re expressing cells (5-HT neurons). This strategy 
results in a 1:1 ratio o f wildtype (from here on referred to as WT; containing central 5-HT 
neurons) and Lm xlb/^/p pups (lacking >99% o f central 5-HT neurons). L m xlb  is a 
transcription factor that is expressed during the embryonic period and is required for 5- 
HT neuron differentiation (Ding et al. 2003). In Lm xlb/^/p mice, the L m xlb  allele is 
flanked by two lox P sites (which contain specific binding sites for Cre) and is excised in 
cells that express the Cre protein (a site-specific DNA recombinase o f loxP sequences).
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Since the Cre protein is expressed only in cells that also express Pet-1 (a transcription 
factor only in cells destined to be 5-HT neurons), the L m xlb  alleles are knocked out 
specifically in Pet-1 neurons. Genotyping was determined by tail tissue samples obtained 
from each mouse and using procedures described by Zhao et al. (2006).
4.2.2. Experimental preparation
Experiments were performed on brainstem slices prepared from W T and 
L m x llf i ,p littermates (post-natal day 1-5) with the investigator blind to the genotype.
Mice were decapitated and the brainstem and spinal cord removed under a flow o f chilled 
artificial cerebrospinal fluid (aCSF) composed of, in mM: 124 NaCl, 25 NaHCC>3, 3 KC1, 
1.5 CaCl2, 1.0 MgSC>4, 0.5 NaH 2P0 4 , 30 D-glucose, and equilibrated with 95% O2 and 
5% CO2 (pH ~7.4). The brainstem was pinned to a wax block, and transverse slices o f the 
medulla (550-600 pm  thick) were prepared using a vibratome (see Smith et al. 1991 for 
details). Slices containing the preBotzinger Complex (preBotC), the hypoglossal motor 
nuclei, and the most rostral hypoglossal nerve rootlets were placed in a recording 
chamber (0.7 ml) and superfused with aCSF at a rate o f 0.7 ml/minute via a syringe pump 
(Harvard Apparatus). The aCSF was warmed to 29°C using a temperature controller 
(W arner Instruments; TC-324B). Potassium concentrations were elevated to 9 mM  to 
ensure rhythmic activity in the slice, as per standard procedures (Smith et al. 1991).
Inspiratory-related motor discharge o f the hypoglossal rootlets was recorded 
continuously by glass suction electrodes. Signals were amplified x 10,000 and filtered (0.3 
-  1 kHz) using a Grass L P 511 AC amplifier and Dagan differential amplifier (EX4-400). 
A Hum Bug noise eliminator (Quest Scientific) was used to reduce 60 Hz noise. Data 
were digitized at 100 Hz and analyzed off-line using M atlab software (MathW orks). 
Analysis o f  hypoglossal root discharge included an initial integration; full wave 
rectification and moving average over 50-msec periods.
4.2.3. Pharmacological agents
All pharmacological agents were obtained from Tocris, stored in stock solution at 
-20°C, and thawed the day o f  an experiment. The following agents were added to the
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aCSF to produce the following final concentrations: hypocretin-1 (Orexin A) (300 nM), 
TCS 0X 2  29 (3 pM), SB-334867 (3 pM) and SB-408124 (3 pM). The hypocretin 
receptor antagonists (TCS 0X 2 29, SB-334867 and SB-408124) were all dissolved in 
DMSO prior to being added to the aCSF, with the final concentration <0.005% DMSO. 
After 30 minutes o f baseline recording, the superfusate was switched to one containing 
either hypocretin-1, SB-408124, or TCS OX2 29 and SB-334867 (these last two agents 
were co-applied) and applied continuously to the slice for 10 minutes. To administer an 
acidotic challenge, the superfusate (pH 7.4) was switched to one o f pH 6.9 for 10 
minutes. Low pH was achieved prior to experiments by adding HC1 to the gas- 
equilibrated aCSF (95% O2 and 5% CO2) and continuously monitoring changes in pH 
with a pH electrode until the value was stable at 6.9.
4.2.4. Data analysis
Integrated hypoglossal nerve discharge was analyzed to determine burst 
frequency, peak burst amplitude, burst duration, duration o f  the period between bursts 
(inter-burst interval), and the coefficient o f variation o f the inter-burst interval (CV IBI; 
calculated as the standard deviation / mean; an indication o f timing variability; Hodges et 
al. 2009 ). Values were averaged from the last two minutes o f baseline immediately prior 
to treatment and the last two minutes o f treatment (either pH change or pharmacological 
agent). All data are presented as mean ± SE or as expressed as a proportion o f the 
baseline value. Statistical significance was evaluated using one-way or two-way ANOVA 
with repeated measures, followed by D unn’s or Bonnferroni’s post hoc analyses for 
multiple comparisons, where appropriate, to compare effects o f  pH, genotype, or drug, 
and their interactions. Additionally, differences between genotype group means of 
baseline burst param eters were compared using a Student’s t-test. The criterion level for 
determination o f  statistical significance was set at P < 0.05 for all data analyses.
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4.3.1. Genotype-induced differences in hypoglossal burst parameters
Under baseline conditions, respiratory-related burst patterns differed between WT 
and L m x lt//f/p preparations (Table 4.1, Fig. 4.1 A). These data were combined from 
baseline periods o f all experimental series (n = 21 W T and 19 L m x lt/^ /p). Hypoglossal 
bursts occurred at 6.8 ± 0.5 bursts/minute in L m xlt/^ /p slices compared to 9.2 ± 0.9 in 
WT. Although this apparent trend matched previous characterizations o f  reduced burst 
frequencies in L m x lt/^ /p preparations (Corcoran et al. 2009b), no statistically significant 
difference between the two genotypes in the present dataset was found (P = 0.055). Burst 
duration was similar between the two genotypes. Respiratory-related output was severely 
disrupted in L m x ll/^ /p as indexed by the coefficient o f  variation o f the interburst interval. 
This param eter was significantly elevated in L m x l t f ^  compared to W T (P  < 0.001), 
indicating significant variability in the hypoglossal burst pattern o f Lm xl t/^/p 
preparations, also apparent in representative tracings (Fig. 4.1 A). This finding was 
consistent with our previous datasets (Corcoran et al. 2009b).
4.3.2. p H  differentially affects hypoglossal burst parameters in WT and L m x lt//f/p 
preparations
Following baseline observations at pH 7.4, preparations were exposed for 10 
minutes to acidotic aCSF with pH 6.9 (Fig. 4.1). This acidosis increased hypoglossal 
burst frequency in W T slices (57 ± 15% change from baseline; n = 12; Fig. 4 .IB). 
Frequency increased gradually once the superfusate containing pH 6.9 reached the slice 
chamber, and after 5 minutes the frequency was significantly elevated (Fig. 4.1C). The 
latency in this response is likely caused by the time required for the recording chamber to 
equilibrate to the pH change, and for the acidic aCSF to diffuse into the tissue. Acidosis 
also increased burst duration (18 ± 5% change from baseline), while burst amplitude was 
unchanged. Acidosis significantly altered burst pattern regularity; the coefficient o f 
variation o f  the interburst interval was reduced (78 ± 8% o f baseline).
4.3. Results
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Responses to acidosis in L m x l 0 /p preparations differed from those o f  WT 
preparations. M ost notably, acidosis did not increase burst frequency in L m x lt/^ /p 
preparations. Like in WT preparations, acidosis did not alter burst amplitude, but did 
increase burst duration in L m x l 0 /p preparations (25 ± 5% increase from baseline; n =
12). Acidosis greatly increased burst regularity in L m xlt/^ /p preparations; the coefficient 
o f variation o f  the inter-burst interval was reduced (50 ± 6% o f baseline), a significantly 
greater decrease than occurred in WT preparations (Fig. 4 .IB).
In both WT and L m x lt//f/p preparations, effects o f pH change were reversible and 
burst parameters returned to baseline values within 10-15 minutes o f  reperfusion with 
normal aCSF (pH 7.4). This switch, however, was accompanied by a significant transient 
decrease in burst frequency observed only in L m x l 0 /p preparations (5 minutes post­
acidosis exposure); however, there was no statistical difference between WT and 
L m x lt//J7p preparations (Fig. 4.1C).
4.3.3. Exogenous hypocretin affects hypoglossal burst parameters
The m ost consistent observation in response to exogenous hypocretin-1 (300 nM), 
in both W T and L m x l 0 /p genotypes, was an increase in tonic activity in the hypoglossal 
nerve (Fig. 4.2A). Exogenous hypocretin-1 had little effect on baseline burst parameters 
(Fig. 4.2). The only significant effect in WT preparations (n = 7) was a decrease in 
hypoglossal burst frequency (to 67 ± 11% o f baseline). This effect was less pronounced 
in L m x l 0 /p preparations (n = 8 ; Fig. 4.2B). Exogenous hypocretin-1 did increase 
regularity o f the hypoglossal burst pattern in Lm xlbf/f/p preparations, as indicated by a 
significant reduction in the CV IBI (to 70 ± 9% o f baseline). Effects o f hypocretin-1 were 
reversible with washout and burst parameters returned to baseline values within 10-15 
minutes.
4.3.4. Blockade o f  endogenous hypocretin affects hypoglossal burst parameters
We examined the influence o f endogenous hypocretin receptor activation by 
determining the effect o f  hypocretin receptor antagonism on hypoglossal nerve output 
using two experimental series with different antagonists (Fig. 4.3). In the first series we
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co-applied SB 334867 (a hcrt-rl antagonist) and TCS 0X 2  29 (a hcrt-r2 antagonist; Fig. 
4.3 A) because a mixed hcrt-rl/-r2  antagonist was not available at the time o f these 
experiments. The second series involved application o f  a single alternative hcrt-rl 
antagonist (SB-408124; Fig. 4.3B). In both WT and L m x l 0 /p preparations, co­
application o f  hypocretin antagonists significantly decreased burst frequency. This effect 
was more pronounced in WT (reduction to 45 ± 4% o f baseline) compared to a more 
modest reduction (to 80 ± 9% o f baseline) in preparations (n=  12 for each
genotype). In the second series, SB-408124 had very similar effects on hypoglossal burst 
frequency (reduction to 38 ± 7% o f baseline in WT, and to 61 ± 6% o f baseline in 
L m x l 0 /p preparations, respectively; Fig. 4.3B; n = 6 for each genotype). Again, the 
reduction in frequency with hypocretin antagonism was more severe in WT preparations. 
Neither antagonist treatment altered burst amplitude. Both antagonist applications 
increased burst duration in WT preparations (by 49 ± 13% above baseline, and 68 ± 22% 
above baseline, for SB-334867 + TCS 0X 2  29 and SB-408124 treatments, respectively). 
Blockade o f hcrt-rl alone using SB-408124 lengthened bursts in L m x lt/^ /p preparations 
(by 41 ± 14% from baseline; Fig. 4.3B)
4.3.5. Effect o f  hypocretin receptor antagonism on the response to acidosis
We examined the influence o f hypocretin receptor antagonists on pH sensitivity 
by exposing slices to solutions with pH 7.4 and 6.9 both without and with hypocretin 
receptor antagonism. Figure 4.4 illustrates changes in hypoglossal burst frequency in 
response to acidosis observed under control conditions (normal aCSF) and blockade o f 
hcrt-r (when aCSF contained either SB-334867 + TCS 0 X 2  29 or SB-408124) alone, in 
both WT and L m x l 0 /p preparations. Despite blockade o f  hypocretin receptors, WT 
preparations exhibited a frequency response to acidosis (increase from 3.4 ± 0.6 to 8.9 ± 
2.0 bursts/minute in the presence o f  both antagonists; increase from 3.0 ± 0.8 to 8.2 ± 1.8 
bursts/minute in the presence o f SB-408124 alone; n = 6 for each drug treatment). 
Switching to pH 6.9 restored the frequency, dampened by antagonists, to a level 
equivalent to baseline control values (control pH 7.4). In L m x l 0 /p preparations, no 
significant frequency response to a change in pH from 7.4 to 6.9 in the presence o f
94
hypocretin antagonists was observed. This paralleled the responses in the absence o f 
antagonists (n = 7 for co-application o f SB-334867 + TCS 0X 2  29; n = 6 for SB- 
408124). Hypocretin antagonism blocked the change in burst duration otherwise 
observed with acidosis in W T preparations (Table 4.2); however, this may have been due 
to an increase in burst duration due to the antagonists themselves (Fig. 4.3). In contrast, 
burst duration increased with a switch to pH 6.9 (see Table 4.2 for changes relative to 
values at pH 7.4) in both the presence and absence o f hypocretin receptor antagonists in 
L m xlt/^ /p preparations. Similar to responses to acidosis alone, burst amplitude did not 
change in response to acidosis in either genotype while hypocretin receptors were 
blocked.
4.4. Discussion
4.4.1. Lm xli/^/p preparations do not respond to acidosis
One o f the major findings o f the current study was that, unlike the response 
normally exhibited in WT preparations, L m xlt/^ /p preparations failed to increase 
hypoglossal burst frequency in response to acidosis. The L m x lt/^ /p mouse, a conditional 
knockout, is a useful model for studying the role o f 5-HT neurons in ventilatory control, 
including the contribution o f 5-HT neurons to central chemosensitivity. Recent work has 
shown that in adults, breathing is relatively stable in L m xlt/^ /p; however, the hypercapnic 
ventilatory response is decreased by -5 0 %  compared to W T (Hodges et al. 2008). In 
contrast, neonates display severely disordered breathing, which can be restored with 
addition o f agonists for 5 -HT2A and NK-1 receptors (Hodges et al. 2009). 
Chemosensitivity has not yet been studied in L m xlt/^ /p mice at young ages. Our data 
demonstrated that, while W T rhythmic medullary slices produced a very robust response 
to a severe change in pH (from 7.4 to 6.9), the frequency o f  hypoglossal bursts was not 
significantly altered in L m xlt/^ /p preparations. As the difference between W T and 
L m xlt/^ /p mice is an almost complete absence o f 5-HT neurons, these data provide 
further evidence that 5-HT neurons are critical in the ventilatory response to hypercapnia. 
Our results demonstrate that 5-HT neurons are critical in generating a frequency response
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to acidosis. While finding 5-HT neurons that are chemosensitive prior to P 12 is rare 
(Wang and Richerson 1999; Wu et al. 2008), the evidence o f the importance o f 5-HT- 
related chemosensitivity in our neonatal preparations is clear. Generally 5-HT neurons 
produce a large response to a change in pH from 7.4 to 7.2 (W ang et al. 2002). 5-HT 
neurons might be chemosensitive at younger ages but may require a larger stimulus.
An interesting observation was made during the return to control pH (7.4) after 
exposure to acidosis. L m x lt/^ /p slices showed a significant decrease in hypoglossal burst 
frequency during recovery from a low pH. This overshoot compared to initial baseline 
suggesting that reversing an acidotic challenge activates chemosensitive receptors that 
inhibit respiratory-related output. A likely candidate may be GABAergic mechanisms 
previously reported in the medullary raphe. Richerson (1995) suggests two distinct 
populations o f raphe neurons that differentially respond to CO 2 in a slice preparation and 
which could alter respiration. Subsequent research has identified two subtypes of 
chemosensitive neurons located in the ventromedial medullary raphe, ‘acidosis- 
stimulated’ neurons (positively identified as 5-HT neurons) and ‘acidosis-inhibited’ 
neurons (W ang et al. 1998, 2002). In addition, acidosis-inhibited neurons are stimulated 
by hypocapnia and alkalosis and are thus considered ‘alkalosis-stim ulated’ neurons. The 
identity o f  these alkalosis-stimulated neurons o f the medullary raphe has been 
characterized as GABA-synthesizing neurons (Corcoran et al. 2008). It is possible that 
the lack o f 5-HT neurons in the L m x lb ^ /p mice leads to an absence o f what would 
normally be an acidosis-stimulated and alkalosis-inhibited neuromodulation o f 
ventilation, revealing a ventilatory depression mediated by activation o f  alkalosis- 
stimulated GABAergic neurons during the transition from pH 6.9 to 7.4. Definitive 
conclusions cannot be drawn, however, regarding the potential masking o f GABAergic 
inhibition as no significant differences in frequency were found between L m x l 0 /p and 
WT preparations.
4.4.2. Hypocretin-1 effects on baseline bursting
Exogenous hypocretin-1 increased tonic hypoglossal nerve activity in both WT 
and L m x lt//J7p preparations. The significance o f this observation is unclear. Hypocretin
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receptors have been localized to a number o f motor neuron pools (Fung et al. 2001; 
Young et al. 2005), and this result may be due to general motom euron activation. Tonic 
hypoglossal nerve activity was not different between W T and L m x lt/^ /p preparations, 
indicating that 5-HT neurons were not involved in this process.
Beyond the general tonic activation, exogenous hypocretin-1 had little effect on 
baseline hypoglossal burst parameters. One curious result was the decrease in 
hypoglossal burst frequency in W T preparations. The physiological relevance o f this 
effect is unclear. The observation that the rhythmic slice was relatively insensitive to 
exogenous hypocretin suggests that the rhythmogenic circuits present in the in vitro slice 
are not normally modulated by hypocretin or that sufficient endogenous hypocretin was 
present in these preparations such that addition o f exogenous hypocretin had no impact. 
This conclusion is also supported by previous observations that exogenous hypocretin 
does not consistently alter phrenic burst discharge in the juvenile arterially perfused rat 
preparation, nor the hypoglossal nerve output in a rhythmic rat medullary slice (Corcoran 
2009).
Exogenous hypocretin-1 enhanced the regularity o f  the hypoglossal burst pattern 
in Lmxlhf^/p preparations. Since this tendency was only observed in the L m x W /J/p slices, 
preparations which lack central 5-HT neurons and were more irregular at baseline 
compared to WT, it suggests that 5-HT is necessary for stability o f the respiratory-related 
rhythm (also supported by evidence from Hodges et al. 2009; Pena and Ramirez 2002; 
Richter et al. 2003). In addition, this instability in Lmxlh/^/p slice preparations can be 
rescued by exogenous hypocretin, although the mechanism is unknown. Thus, 5-HT 
neuron contribution to the stability o f  the respiratory rhythm can be by-passed by a 
hypocretinergic mechanism. Other contributors that appear to restore breathing stability 
caused by a lack o f  5-HT include substance P and elevated potassium (Hodges et al. 
2009).
Anatomical and functional evidence indicate that endogenous hypocretins 
modulate breathing. Axons o f hypocretin-containing neurons project from the 
hypothalamus to respiratory-related nuclei including the nucleus tractus solitarius (NTS),
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preBotC, the locus coeruleus, and hypoglossal and phrenic nuclei (Fung et al. 2001; 
Hagan et al. 1999; Nakam ura et al. 2007; Young et al. 2005). Also, areas corresponding 
to the preBotC and the phrenic motonuclei are immunoreactive for hcrt-rl receptors 
(Young et al. 2005) and hypoglossal motor neurons express hcrt-r2 (Volgin et al. 2002). 
Information from patients with various respiratory disorders also hint at a correlation 
between breathing and hypocretins. Patients with Guillain-Barre syndrome, a syndrome 
often associated with respiratory paralysis, have low levels o f  hypocretin in their 
cerebrospinal fluid (Ripley et al. 2001). Patients with sleep apnea have low blood levels 
o f  hypocretin (Sakurai et al. 2005).
In addition, physiological experiments indicate that hypocretins enhance 
ventilation. Injection o f  hypocretin-1 into the lateral ventricle o f  a urethane-anesthetized 
mouse results in a small increase in breathing frequency (~ 1 1 %) and a larger increase in 
tidal volume (~75%) (Zhang et al. 2005). Administration o f hypocretin-1 into the 
preBotC increases diaphragmatic electromyogram activity but does not affect breathing 
frequency (Young et al. 2005). This is suggestive that hypocretin stimulates respiration 
primarily through increases in tidal volume (Young et al. 2005). Nonetheless, the 
importance o f the role o f the hypocretinergic system in breathing remains unclear, as the 
respiratory phenotype (both breathing frequency and tidal volume) o f  a knockout mouse 
that lacks both hypocretin-1 and -2 is not significantly different than W T (Nakamura et 
al. 2007). Our findings indicated that exogenous application o f  hypocretin-1 (which 
targets both types o f  hypocretin receptors) reduced hypoglossal burst frequency in WT 
medullary slice preparations, while this treatment had no influence in L m x ll/^ /p slices. 
This result is in contrast with more intact animal studies listed above, where hypocretin 
either had no effect on breathing frequency or increased it. This discrepancy may be due 
to influences not present in the reduced slice preparation.
4.4.3. Hypocretin antagonists have more severe effects on hypoglossal activity in WT
Addition o f hypocretin antagonists to the aCSF resulted in changes in the 
hypoglossal burst output o f both WT and L m x ll//f/p preparations. As hypocretin
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antagonists should have an influence only if  hypocretin receptor activation is present, we 
conclude that endogenous hypocretin was still present in the slices.
Hypocretin neuropeptides are synthesized exclusively in the lateral hypothalamus 
(Sakurai et al. 1998), an area that is absent in the in vitro rhythmic medullary slice 
preparation. However, these hypothalamic neurons project widely throughout the 
brainstem (Peyron et al. 1998), and it is feasible that a quantity o f  endogenous hypocretin 
is stored at synaptic terminals. This would explain how addition o f  hypocretin receptor 
antagonists could have significant effects in a preparation that lacks hypocretin neuronal 
cell bodies. The sources o f  endogenous hypocretin, blocked by antagonists, are unknown. 
We speculate that the elevated potassium concentrations used in the perfusate may induce 
spontaneous synaptic release o f  hypocretin despite the isolation o f hypocretin nerve 
terminals, present in the slice, from their hypothalamic cell bodies. An alternative 
explanation, however, is that the antagonists used bind to other types o f receptors. Co­
application o f antagonists for both hypocretin receptors resulted in a similar reduction in 
hypoglossal burst frequency as did blockade o f  hcrt-rl alone (Fig. 4.3). Thus, facilitation 
o f the respiratory-related rhythm by endogenous hypocretin is likely primarily through 
activation o f h c rt-r l. An alternative explanation, however, is based on the differential 
expression o f hypocretin receptors during development. While hcrt-rl gene expression 
gradually increases from PO to P25, expression o f hcrt-r2 is not detected in the 
paraventricular nucleus (a site o f  high hcrt-r2 expression in adult rats) at PO or P I, is only 
weakly expressed at P5, and then gradually increases until P20 (Yamamoto et al. 2000). 
While this could explain our current results, one m ust be cautious o f  such interpretation 
as these experiments were performed in rats (while ours were conducted in mice), and 
these species may differs in developmental expression o f  hypocretin receptors.
The effects o f  hypocretin antagonism were more profound in WT than L m xli/^ /p 
preparations. Again as the differences between these two genotypes are associated with a 
lack o f central 5-HT neurons in L m x l 0 /p mice, these data suggest that facilitation o f  the 
respiratory rhythm by hypocretin was mediated, in part, through activation o f  5-HT 
neurons. An anatomical basis for such interactions exists. Low density expression o f
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both hcrt-rl and hcrt-r2  is found in the raphe magnus, while in the raphe obscurus hcrt-rl 
is modestly expressed and no expression o f  hcrt-r2 is present (Marcus et al. 2001). Also, 
hypocretin axon terminals are found in the raphe magnus and pallidus (Nambu et al.
1999). A much denser innervation o f  hypocretin-1 fibers is observed in the raphe pallidus 
(Zheng et al. 2005). While neurophysiological recordings have not been made from the 
medullary raphe, hypocretin-1 depolarizes dorsal raphe 5-HT neurons (Brown et al. 2001; 
Takahashi et al. 2005). I f  the influences o f hypocretin antagonism are dependent on 
hypocretin receptor activation on raphe 5-HT neurons, then the lack o f such neurons in 
L m xlb17f/p slices would explain the limited impact o f hypocretin in this genotype.
4.4.4. Hypocretin affects the p H  response
We also sought to determine whether hypocretins modulate the ventilatory 
response to acidosis, and if  so, whether this is through excitation o f 5-HT neurons. To do 
this we compared hypoglossal burst responses to low pH in rhythmic medullary slices 
derived from wildtype and L m xll/^ /p mice before and during hypocretin receptor 
antagonism. While baseline (pH 7.4) frequency was markedly lower in preparations 
where hypocretin receptors were blocked, burst frequency increased in a similar fashion 
in response to pH 6.9 as did the control slices (which lacked the hypocretin receptor 
antagonists). This suggests that hypocretin did not enhance or promote the response to 
acidosis. Such a result is in contrast to our data from arterially perfused in situ  rats, where 
systemic administration o f SB-408124 inhibited the ventilatory hypercapnic response 
(Corcoran 2009), and other reports that hypocretins modulate chemosensitivity (Dias et 
al. 2009; Nakamura et al. 2007). Yet to be determined impacts o f  species (rat vs mouse) 
and age (juvenile vs neonate) may contribute to such responses. The m ost likely basis for 
the difference, however, is that the elements responsible for the observation that 
hypocretin receptor antagonist-mediated attenuation o f chemosensitivity occur outside 
the rhythmic slice.
Since acidosis did not induce a change in hypoglossal burst frequency in 
L m x ltf7f/p preparations, the lack o f  response in the presence o f  hypocretin receptor
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antagonists is not unexpected and does not give us any inform ation as to the importance 
o f hypocretin in such a response.
The only evidence alluding to a hypocretinergic facilitation o f the hypercapnic 
response due to an interaction with the 5-HT system is based on changes in hypoglossal 
burst duration. In W T preparations, bursts were significantly longer during exposure to 
pH 6.9 than during exposure to pH 7.4. Blockade o f hypocretin receptors eliminated this 
response. In L m x lt//f/p preparations, a similar lengthening in hypoglossal bursts was 
observed at pH 6.9 compared to pH 7.4; however, hypocretin receptor antagonism did not 
inhibit this response as it did in WT. How and whether this increase in duration is 
mediated by 5-HT neurons remains unknown.
4.4.5. Implications fo r  arousal
We cannot assess the arousal state in an in vitro slice preparation and, therefore, 
cannot directly determine the link between arousal, hypocretin, and 5-HT. This may be o f 
consequence as much evidence indicates that involvement o f  the hypocretinergic system 
in the hypercapnic ventilatory response is arousal-state dependent; hypocretin plays a 
more significant role during wakefulness (Dias et al. 2009; Nakam ura et al. 2007). This 
complements observations that hypocretin neurons fire spontaneously during wake 
periods and less, or not at all, during sleep (Estabrooke et al. 2001; Lee et al. 2005).
Given the anatomical and physiological evidence linking the hypocretinergic and 
serotonergic systems, and the involvement o f both o f these systems in arousal, they 
possibly interact to promote a response to hypercapnia. Lack o f  a physiological correlate 
o f arousal may explain why hypocretin antagonism does not alter the hypoglossal burst 
frequency response to acidosis in the medullary slice preparation.
In summary, we have shown that 5-HT neurons are required for the frequency 
response to severe acidosis in the in vitro rhythmic medullary slice preparations, 
furthering evidence that they are critically involved in central chemoreception.
Exogenous application o f  hypocretin-1, as well as hypocretin receptor antagonism, 
differentially alters respiratory-related output in WT and L m x l 0 /p preparations, 
suggesting that 5-HT neurons contribute to the role o f hypocretin in fictive ventilation.
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While we do not have evidence that hypocretin contributes to the frequency response to 
acidosis, this neuropeptide appears to facilitate the acidosis-induced increase in 
hypoglossal burst duration via modulation o f 5-HT neurons.
Figure 4.1. Acidosis differentially affects hypoglossal burst parameters in rhythmic slices from 
neonatal wildtype (WT) and Lmxlhffp mice. A) Raw and integrated traces from both genotypes at 
normal pH (7.4) and during acidosis (pH 6.9). Lmxlbf/f/p bursting is more irregular and generally 
slower compared to WT during control conditions. B) Mean changes in burst frequency, 
amplitude, duration, and coefficient of variation of the interburst interval (CV IBI) in response to 
acidosis. Data are mean values ± SE expressed as a percentage of control values. Acidosis 
increases burst frequency in WT preparations only. C) Time course of mean burst frequency ± SE 
in both genotypes during control conditions (pH 7.4), acidosis (pH 6.9), and washout (ie. return to 
normal aCSF). * indicates a statistically significant difference from baseline levels, and t  
indicates a significantly different response in the two genotypes (n = 12 for each genotype; B) 
two-way RM ANOVA, C) one-way RM ANOVA; P < 0.05).
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Figure 4.2. Effects of application of exogenous hypocretin-1 (300 nM) in wildtype (WT) and 
Lmxlhf/f/p rhythmic slices. A) Raw and integrated traces from both genotypes perfused with 
normal aCSF and during exposure to hypocretin. An increase in tonic activity was commonly 
observed in the presence of exogenous hypocretin. B) Mean changes in burst frequency, 
amplitude, duration, and coefficient of variation of the interburst interval (CV IBI) in response to 
hypocretin. Data are mean values ± SE expressed as a percentage of control values. Exogenous 
hypocretin reduced instability in L m xllff/p preparations. C) Time course of burst frequency in 
both genotypes during control conditions and during application of hypocretin. * indicates a 
statistically significant difference from baseline levels (ie. no hypocretin; n = 7 for WT and n = 8 
for Lm xlo!f/p\ two-way RM ANOVA, P < 0.05).
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Figure 4.3. Hypocretin receptor antagonism effects on hypoglossal burst frequency, amplitude, 
and duration. A) Responses to co-application of hcrt-rl and hcrt-r2 antagonists (SB-334867 and 
TCS OX2 29, respectively; 3 pM each; n = 12 for each genotype). B) Responses to a different 
hcrt-rl antagonist, SB-408124 (3 pM; n -  6 for each genotype). Data are mean values ± SE 
expressed as a percentage of control. * indicates a statistically significant difference from control, 
and f  indicates a significantly different response between the two genotypes (2-way-RM- 
ANOVA, P < 0.05).
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A)
B)
Figure 4.4. Burst frequency response to pH 6.9 and the impact of hcrt-rl and hcrt-r2 antagonists 
on this response in WT and Lm xll/,f'p preparations. A) Co-application of 3 pM SB-334867 and 3 
pM TCS 0X2 29 (open circles) compared to control (filled circles). B) Application of 3 pM SB- 
408124 (open circles) compared to control (filled circles). Data presented are mean values ± SE. 
* indicates a statistically significant difference (paired t-test, P < 0.05) from values at pH 7.4.
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Table 4.1 Baseline hypoglossal burst parameters from  WT and Lm xH /^/p rhythmic
medullary slices
Genotype n
Frequency
(bursts/min)
Duration
(sec)
CV IBI
W ildtype 19 9.2 ± 0 .9 0.66 ± 0 .4 0.28 ± 0.024
L m x ltf/f/p 2 1 6.8 ±0 .5 0.68 ± 0.2 0.44 ±0.026*
Data are mean ± SE. A M est (* P < 0.001) or Mann-W hitney rank sum test was used, as 
appropriate, to determine a statistically significant difference from WT.
Table 4.2 Effects o f  hypocretin receptor antagonism on the p H  response in WT and L m xlt/^ /p rhythmic 
medullary slices
Genotype n Treatment
Burst duration at pH 6.9 
as a percentage o f control
Burst amplitude at pH 6.9 
as a percentage o f control
Wildtype 6 SB-334867 + TCS 0X 2 29 100  ± 10 93 ± 3
6 SB-408124 107 ± 7 93 ± 6
L m x ll//f/p 7 SB-334867 + TCS 0X 2 29 12 0  ± 7 * 100 ± 4
6 SB-408124 119 ± 3 83 ± 12
Data are mean ± SE. A paired t-test was used to determine statistical significance o f values at pH 6.9 compared to 
baseline (pH 7.4). * P < 0.05
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Chapter 5 General discussion
5.1. Using reduced preparations to examine neuroventilatory modulation
Central CO2 chemosensitivity has been extensively investigated in a wide variety 
o f animal preparations. Since Mitchell et al. (1963) first discovered central 
chemosensitive neurons on the ventral medulla o f  the cat, the identification o f 
populations o f specific chemoreceptors and their interactions have been made using 
preparations ranging from isolated neurons to intact animals (Nattie and Li 2001; Wang 
et al. 1998). Throughout my dissertation, I investigated neuroventilatory CO2 sensitivity 
using the arterially perfused in situ  preparation and the in vitro rhythmic medullary slice 
preparation.
5.1.1. The in situ preparation as a tool to examine effects o f  CO2 on ventilation
M uch o f  the work in this dissertation utilized a rat model, the arterially perfused 
in situ juvenile rat brainstem preparation, as a means to study the hypercapnic ventilatory 
response. This preparation is advantageous as it maintains the complexity o f  respiratory 
networks in an unanesthetized animal. This is important in that previous research has 
been conducted prim arily on reduced preparations (cell culture and brainstem slices) or in 
the presence o f anesthetic agents, which have potential confounding influences. The 
perfused brain reduces traum a to the central nervous system and peripheral nerves during 
surgery, as compared to more reduced preparations such as acute slices. The brain also is 
less likely to suffer from ischemia than more reduced preparations as the dissection time 
is fast and the aorta is cannulated quickly to perfuse the brain with artificial cerebrospinal 
fluid (aCSF) through the normal vasculature. Also a key benefit to using the in situ 
preparation is that it maintains integrative function o f  central networks. Less reduced 
preparations, such as those studied in vivo, are potentially compromised by anesthesia, 
which is known to blunt the hypercapnic chemoresponse (M artin-Body and Sinclair 
1985). Protocols using the in situ  preparation are carried out in the absence o f anesthesia 
as pain perception is abolished by decerebration. This preparation also permits easy
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pharmacological manipulation and control o f external variables (such as temperature,
CO2 and O2 levels).
My data showed that this preparation exhibited CO2 sensitivity that is 
intermediate to more intact animals and more reduced preparations like brainstem slices. 
Several datasets showed the in situ juvenile rat preparation was responsive to both mild 
(7%) and severe (9-10%) hypercapnia, as determined by significant changes in phrenic 
nerve output (Chapters 2 and 3). This is in agreement with responses published by other 
investigators (Day and W ilson 2005, 2007; St-John and Paton 2000). The responses I 
observed in phrenic burst frequency and amplitude in response to hypercapnia in the in 
situ preparation were dampened compared to ventilatory responses observed in vivo. This 
was to be expected, however, as many influences known to facilitate ventilation and 
chemosensitivity, but originating outside the brainstem, were absent from my 
preparations. The in situ  preparations have deactivated peripheral chemoreceptors, are 
vagotomized, decerebrate, and slightly hypothermic - all factors known to reduce the 
hypercapnic ventilatory response (Gautier et al. 1993; Hayashi and Sinclair 1991; Martin- 
Body and Sinclair 1987; M askrey 1990; Nattie et al. 1991).
5.1.2. The in vitro slice preparation as a tool to examine mechanisms and modulation 
o f  neuroventilation
The in vitro medullary slice preparation provided investigative benefits by 
targeting a limited section o f  nuclei within the brainstem. W hile hypoglossal rhythmic 
activity recorded in these preparations may not represent eupnea directly (St-John 1996), 
medullary preparations allowed precise manipulations o f  elements w ithin the slice. This 
gave me the ability to investigate putative rhythmogenic elements located in the slice, in 
the absence o f  external influences. While I must be cautious when extrapolating results to 
the whole animal, data from in vitro slices provide information indicating actions central 
in origin.
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5.1.3. The utility o f  slices derived from  genetically modified mice
I also used in vitro slice preparations derived from knockout mice lacking all 
central serotonin neurons { L m x l0 /p mice; Ding et al. 2003; Zhao et al. 2006). The 
L m xlt/^ /p knockout mouse facilitated investigation o f 5-HT neurons in neuroventilation 
and responses to acidosis. This genetic alteration o f  central 5-HT neuron expression 
provides targeted and specific deletion o f 5-HT neurons (>99%). Other studies using 
pharmacological deletion or inhibition o f 5-HT neurons do not im pact the system to such 
an extent (M essier et al. 2002, 2004; Nattie et al. 2004; Taylor et al. 2005). Although the 
in vitro slice preparation is limited to use in neonates, this is beneficial as many o f the 
respiratory abnormalities in the L m xll/^ /p mice disappear with age due to compensatory 
mechanisms occurring during development (Hodges et al. 2008, 2009). Using in vitro 
slices derived from neonatal L m xll/^ /p mice illustrates the roles o f  5-HT neurons in 
normal respiratory function prior to this potential compensation.
5.2. Neurotransmitter systems that contribute to central chemosensitivity
5.2.1. Role o f  5-HT system in central respiratory chemosensitivity
Results from my experiments have documented the critical nature o f 5-HT 
neurons and identified the post-synaptic 5-HT mechanism that promotes ventilation 
during hypercapnia. Previous research proposes the importance o f  5-HT neurons 
themselves (and thus 5-HT as an important modulator) in the hypercapnic ventilatory 
response (Hodges et al. 2008; M essier et al. 2004; Nattie et al. 2004; Taylor et al. 2005). 
However, none have shown which post-synaptic receptor subtype is prim arily responsible 
for the augmentation in phrenic nerve output in an intact system. I clearly demonstrated 
that 5-HT neuron activation and activation o f 5 -HT2 receptors were critical in producing 
both the frequency and amplitude increases in phrenic bursts associated with hypercapnia 
(Fig. 2.5).
I also re-examined the role o f 5-HT neurons themselves in central 
chemosensitivity. This was achieved in two ways: 1) by inhibiting 5-HT neurons with 8- 
OH-DPAT in the in situ  rat preparation and evaluating the response to systemic
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hypercapnia, and 2) by comparing the response to changes in pH in medullary slice 
preparations from wildtype (WT; containing 5-HT neurons) and L m x ll//f/p mice (which 
lack central 5-HT neurons) (Ding et al. 2003; Zhao et al. 2006). The phrenic burst 
frequency response normally associated with elevated CO2 in the in situ  preparation was 
not observed when 8-OH-DPAT was added to the perfusate (Fig. 2.4). These results 
illustrated that an 8-OH-DPAT-sensitive process was critical for the hypercapnic 
response. 8-OH-DPAT activates 5-HTiA autoreceptors on 5-HT neurons, hyperpolarizing 
and effectively silencing these cells, and reducing their release o f  neurotransmitters 
(McCall and Clement 1989; Veasey et al. 1995). My results support a conclusion that 5- 
HT neuron activity is critical for chemosensitivity.
In addition to the in situ  rat preparation, I made use o f  the transgenic L m x ll//f/p 
mouse in my investigation o f  the role o f  5-HT neurons in ventilation and 
chemosensitivity. In a neonatal in vitro rhythmic medullary slice preparation, I 
demonstrated that WT responded to acidosis (pH 6.9) by significantly increasing 
hypoglossal burst frequency, while this response was absent in L m x ll//f/p (Fig. 4.1). As 
the normal chemoreflex is absent in the system lacking 5-HT neurons, I conclude that 
such neurons are again critical for chemosensitivity. Both results from the in situ and in 
vitro experiments are complementary and support a conclusion that 5-HT neurons are 
critical in central chemosensitivity.
5.2.2. Role o f  hypocretinergic system in central respiratory chemosensitivity
Data suggest that hypocretin-synthesizing neurons may themselves be 
chemosensitive, increasing their firing rate in response to CO2 (Sunananga et al. 2009). 
Also, hypocretins appear to modulate both ventilation and chemosensitivity, particularly 
during wakefulness (Dias et al. 2009; Nakamura et al. 2007). Some o f the mechanisms 
involved in such modulation may be associated with non-5-HT neurons located outside 
the raphe (Dias et al. 2009). Results from the in situ  preparation indicated that exogenous 
hypocretin application had little or no effect on ventilation or chemosensitivity (Fig. 3.1). 
I concluded from this that either hypocretins had no influence or that endogenous 
hypocretin was sufficient. As both baseline ventilation and chemosensitivity were
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preserved, my data do not support a role o f hypothalamic hypocretin-synthesizing 
neurons as important chemoreceptors. Both the in vitro rat and mouse slices were 
relatively insensitive to exogenous hypocretin (Fig. 3.1, Fig. 4.3). In particular, this 
treatment did not emulate the change in burst frequency in the mouse slice associated 
with a response to acidosis (Fig. 4.1). These data further refute the role o f hypocretin in 
chemosensitive neurotransmission.
In the in situ  preparation, chemosensitivity was not observed when endogenous 
hypocretin receptor activation was blocked. Thus, endogenous hypocretin facilitated 
central chemosensitivity through activation o f  hypocretin receptors type 1 (hcrt-rl; Fig. 
3.2). I conclude that, although hypocretin neurons may not play a direct role in 
chemosensation, hypocretin neuropeptides provide a critical facilitation necessary for 
chemosensitive mechanisms to function. Curiously, antagonism o f hypocretin receptors 
in in vitro mouse slices did not impact the increase in hypoglossal burst activity 
associated w ith acidosis (Fig. 4.4). Clearly, this in vitro slice was capable o f generating a 
chemosensitive response without hypocretin receptor activation. In contrast, hypocretin 
receptor activation was critical for central chemosensitivity o f  the in situ  rat preparation. 
The cause o f  disparity regarding the role o f hypocretin in central chemosensitivity in 
these two preparations has not been identified. This disparity could result from a 
difference between the species (mouse vs rat), the level o f maturity o f the preparations 
(neonatal vs juvenile rat), or the degree o f reduction (in vitro brainstem slice vs in situ 
arterially perfused brainstem). Understanding these differences is an obvious future 
direction for this research.
5.3. Respiratory control-related interaction between the serotonergic and 
hypocretinergic systems
Growing evidence suggests that central chemoreception is achieved by multiple 
potential interaction sites within the brain (Nattie and Li 2009). A recent publication 
shows a significant link between hypocretins and chemoreception in the retrotrapezoid 
nucleus and between hypocretins and 5-HT neuron function in the midbrain raphe
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(Brown et al. 2001; Dias et al. 2009). The anatomy for a similar interaction between 
hypocretins and 5-HT neurons exists since hypocretin receptors 1 and 2 are present in the 
medullary raphe, and projections o f  hypocretin neurons terminate in that area (Marcus et 
al. 2001; Nam bu et al. 1999; Zheng et al. 2005). My results showed a functional 
interaction between hypocretins and 5-HT neurons. I compared the effects o f hypocretin 
receptor antagonists on baseline hypoglossal burst parameters in rhythmic slices derived 
from both WT and L m x ltf/f/p mice. Blocking endogenous hypocretin significantly 
decreased burst frequency in preparations from both genotypes; however, this depression 
was more severe in WT preparations (Fig. 4.3). This indicates not only that hypocretin 
was facilitating respiratory-related nerve discharge, but also that part o f this modulation 
was through activation o f 5-HT neurons.
5.4. Ventilatory chemosensitivity and Sudden Infant Death Syndrome (SIDS)
I have shown that an experimentally induced dysfunction o f  the 5-HT system 
compromised critical homeostatic reflexes. If  such dysfunction occurred in an infant, 
vulnerability to SIDS would be enhanced. Furthermore, the medullary 5-HT systems o f 
humans and rats are sufficiently similar, and ample evidence o f  5-HT anomalies among 
SIDS victims (Kinney et al. 2001, 2003; Kinney 2005) shows that 5-HT dysfunction can 
be considered a likely cause o f at least a subset o f SIDS cases. The implications o f this 
causational understanding o f  SIDS is that diagnostic and therapeutic tools aimed at SIDS 
might be well advised to target the 5-HT system.
5.4.1. The medullary 5-HT system in humans and rats
The medullary 5-HT system consists o f  5-HT-containing neurons located in the 
midline raphe (raphe pallidus, raphe magnus, and raphe obscurus), the lateral extraraphe, 
and the ventral surface o f  the medulla (Kinney et al. 2001; Paterson et al., 2006b; 
Richerson 2004). In humans, central 5-HT neurons are in homologous regions to those in 
rodent brainstems (Paterson et al. 2009). However, an additional component is defined in 
the human system, the arcuate nucleus (Kinney 2005). This nucleus is positionally 
analogous to 5-HT and glutamatergic neurons o f  the ventral medullary surface in rats
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(Paterson et al. 2006a). In rodents, these neurons are chemosensitive and this appears to 
be true for neurons in the arcuate nucleus as well. Functional neuroim aging o f  adults 
breathing elevated CO2 shows an increase in firing in this area (Gozal et al. 1994). Also, 
the arcuate nucleus was absent in the autopsied brain o f an infant who was insensitive to 
CO2 (Folgering et al. 1979). Additionally, tracing studies show that 5-HT neurons in the 
human medullary raphe project to respiratory-related nuclei such as the nucleus tractus 
solitarius (NTS) and hypoglossal nuclei (Paterson et al. 2009). Similar projections are 
observed in rodents (Dahlstrom and Fuxe 1964; Jelev et al. 2001). The medullary 5-HT 
system o f humans and rats, thus, seems functionally and anatomically disposed to playing 
a significant role in respiratory CO2 chemosensitivity.
Furthermore, consistent distributions o f  5-HT2A receptors have been described in 
the medulla o f  humans and rats in nuclei critical for respiratory control (Paterson and 
Damall 2009). 5-H T ia receptors co-localize primarily with 5-HT neuronal cell bodies in 
the human, which is similar to the rodent distribution (Paterson et al. 2006a).
5.4.2. Medullary 5-HT dysfunction in SIDS brainstems and the relevance o f  current 
findings
The medullary 5-HT system is abnormal in -5 0 %  o f SIDS cases (Kinney et al. 
2001, 2003; Kinney 2005). 5-HT receptor binding densities are lower in the arcuate 
nucleus and the raphe obscurus in SIDS cases. Specifically 5-H TiA and 5 -HT2A receptor 
expression is significantly lower in SIDS cases compared to age-matched controls 
(Paterson et al. 2006b). Additionally, the number and density o f  5-HT neurons is 
significantly higher in SIDS cases in regions o f  the raphe; however, many o f these 
neurons are immature (Paterson et al. 2006b). Such abnormalities do not indicate if  there 
is an excess or a deficit o f available 5-HT. Recent evidence, however, suggests that the 
level o f  available 5-HT in SIDS versus normal brainstems is lower (Broadbelt et al.
2009). Collectively, these findings suggest that the 5-HT dysfunction, which putatively 
underlies SIDS, is based on receptor dysfunction and a deficiency in 5-HT production.
If  I compare my experimentally induced abnormalities with those found in SIDS 
brainstems, I can postulate how a dysfunction in the 5-HT system, in addition to an
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exogenous stressor such as hypercapnia, may contribute to SIDS. Complete inhibition o f 
5 -HT2 receptors with ketanserin eliminated the neuroventilatory response to CO2 in the in 
situ rat preparation (Fig. 2.5). If  I evaluate this result with the decrease in 5-HT2A 
receptors found in SIDS cases, I can speculate that such a decrease may blunt the 
hypercapnic ventilatory response, a critical homeostatic reflex whose dysfunction could 
result in death. Additionally, I presented physiological evidence that indicated the 
importance o f 5-HT neurons and 5-HT release in central chemosensitivity (i.e. 8-OH- 
DPAT eliminated the hypercapnic response in situ  and the response to acidosis in 
medullary slices derived from L m x l 0 /p mice was absent) (Fig. 2.4, Fig. 4.1). The 
recently reported decrease in 5-HT levels in SIDS cases could reflect a diminished ability 
to respond to CO2 as an exogenous stressor.
A role for 5 -HT2A receptors in respiratory CO2 chemosensitivity and a 
developmental change in the expression o f  this receptor subtype may combine to provide 
the third component o f  the triple-risk model for SIDS. In addition to an underlying 
vulnerability and an exogenous stressor, SIDS occurs during a critical developmental 
period o f homeostatic control (Filiano and Kinney 1994). I provided evidence for the 
importance o f 5-HT2 receptors in the response to hypercapnia (Fig. 2.5). A significant 
reduction in the expression o f this receptor subtype is reported in several respiratory- 
related nuclei in rats at post-natal day 12, after which expression increases again (Liu and 
Wong-Riley 2009). Thus it is possible that this reduction in the function o f the 5-HT 
system during such a critical period may render the animal naturally and transiently less 
able to respond to an exogenous stressor, such as hypercapnia. If  a dysfunction in the 5- 
HT system is superimposed onto this transient period o f reduced function, the ability to 
respond to hypercapnia may be severely reduced.
5.5. Summary
The 5-HT system o f the medullary raphe is critical in central chemosensitivity. 
Using both the in situ  brainstem preparation derived from rats and the in vitro medullary 
slice preparation from mice, I verified that 5-HT neurons were critical in generating a
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response to CO 2, and that release o f 5-HT from neurons activated by hypercapnia 
facilitated the respiratory rhythm through 5-HT2 receptors. Hypocretins played a 
significant role in the neuroventilatory response to CO2, prim arily through activation o f 
hcrt-rl, which may mediate the activity o f 5-HT neurons. M edullary slice preparations 
from mice indicated that hypocretins mediate the hypoglossal burst duration response to 
CO2 via 5-HT mechanisms. I also found that hypocretins facilitated baseline neural 
ventilatory output in part through 5-HT neurons. Thus, both the 5-HT and 
hypocretinergic systems are involved in modulating ventilation and hypercapnic 
ventilatory responses.
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